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Abstract 
 
Lectins are proteins capable of specifically binding to glycans. This characteristic makes them 
unique molecules in cell recognition, especially of anomalous cells, since they have on their surface 
characteristic receptors. In addition to being of extreme importance in cell recognition, lectins have 
been described as capable of inducing cell death in various types of cancer, through several 
processes, namely, apoptosis and autophagy. Thus, because lectins are widely distributed in nature, 
with plants being one of the largest reservoirs, and have particular characteristics, these proteins 
are a topic of intense research. 
Colorectal cancer is the third most common cancer in men and the second most common in 
women. Phenotypic changes may be due to post-translational modifications, namely, changes in 
protein glycosylation, more specifically in N-glycosylation. N-glycans are of extreme importance 
in tumorigenesis, since they are involved in several cellular mechanisms, such as metabolization, 
signaling, growth, cell adhesion, cell-matrix interaction, invasion and metastasis.  
The studies presented in this thesis aimed to discovery new lectins, present in Mediterranean 
flora species, with capacity to specifically interact with colorectal cancer cells and induce cell 
death.  
After protein separation of lectins present in the protein extracts of the selected species, Arbutus 
unedo, it was found that the protein of interest appears to have a molecular weight of ≈ 15 kDa, 
being able to interact with HT29 human colon cancer cell membranes. In antitumor activity assays 
in HT29 cells, the purified protein increased cell death and decreased cell viability. However, when 
compared to the protein extract, the purified protein showed less activity in both assays. Caspases-
3/7 activity assays and nuclear fragmentation assays suggest that cell death may not occur through 
apoptosis under these experimental conditions. 
In conclusion, we show the presence of lectins in the studied species, and the purified lectin 
demonstrated binding capacity and antitumor activity for the HT29 cells.  
 
Key Words: Lectins; colorectal cancer; aberrant glycosylation; apoptosis; necrosis 
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Resumo 
 
As lectinas são proteínas com capacidade de se ligarem de forma específica a glicanos. Esta 
característica torna-as moléculas únicas no reconhecimento de células, nomeadamente de células 
anómalas, uma vez que estas têm na sua superfície recetores glicosilados característicos. Para além 
de serem de extrema importância no reconhecimento celular, as lectinas têm sido descritas como 
tendo capacidade de induzir morte celular em diversos tipos de cancro, através de inúmeros 
processos, nomeadamente apoptose e autofagia. Assim, pelo facto de se encontrarem extensamente 
distribuídas na natureza, sendo as plantas um dos maiores reservatórios de lectinas, e devido às 
suas características, estas proteínas são alvo de intensa investigação. 
O cancro colon retal é o terceiro cancro mais comum nos homens e o segundo mais comum nas 
mulheres. O desenvolvimento e progressão deste tipo de cancro deve-se à acumulação de alterações 
genéticas, nomeadamente alterações que afetam a proliferação, a sobrevivência, a migração e a 
invasão destas células para outros tecidos. Ocorrem também alterações fenotípicas, devido a 
modificações pós-tradução, incluindo modificações na glicosilação proteica, mais em concreto da 
N-glicosilação. Os N-glicanos são de extrema importância no processo tumoral, uma vez que estão 
envolvidos em diversos mecanismos celulares, como a metabolização, a sinalização, o crescimento, 
a adesão entre células, a interação célula-matriz, a invasão e a metastização. Todas estas alterações 
conduzem ao avanço progressivo da doença sendo que, apesar dos significativos avanços no 
tratamento do cancro colon retal, os doentes metastáticos apesentam uma taxa de sobrevida a 5 
anos limitada a 13%. É, por isso, imperativo encontrar novas alternativas terapêuticas. 
Os estudos apresentados nesta tese tiverem como principal objetivo a procura de novas lectinas, 
presentes em espécies da flora mediterrânea, com capacidade de interagirem de forma específica 
com as células do cancro colon retal e induzirem morte celular. Selecionamos quatro espécies da 
flora mediterrânica, sendo algumas endémicas da flora portuguesa (Juniperus oxycedrus subsp. 
oxycedrus, Juniperus oxycedrus subsp. badia, Arbutus unedo e Corema album). Todas exibem 
atividade hemaglutinante ao nível do extrato proteico, sugerindo a presença de proteínas do tipo 
lectinas. Estas espécies foram avaliadas em termos de atividade antitumoral, sendo que 
prosseguimos com a espécie que apresentou melhores resultados (Arbutus unedo), de forma a 
isolarmos a(s) lectina(s) responsável(eis). Para a lectina purificada fez-se a sua caracterização 
xvi 
 
proteómica e avaliou-se a sua atividade antitumoral assim como os mecanismos conducentes à sua 
citotoxicidade sobre as células humanas HT29, do cancro do cólon. 
Os resultados apresentados mostram que todas as espécies estudadas têm capacidade de induzir 
morte celular e diminuir o metabolismo celular. No entanto, o Arbutus unedo foi a espécie que 
mais se destacou, quando comparado com os resultados anteriores obtidos nestas espécies. Para a 
espécie seleccionada, Arbutus unedo, após separação proteica das lectinas presentes no extrato, 
verificou-se que a proteína de interesse aparenta ter um peso molecular de ≈ 15 kDa, sendo capaz 
de se ligar às membranas das células HT29. Em relação aos ensaios de atividade antitumoral nas 
células HT29, a lectina purificada apresenta capacidade de aumentar a morte celular e diminuir a 
viabilidade celular; no entanto, quando comparado com o extrato proteico, este apresenta melhores 
resultados em ambos os ensaios. No que diz respeito ao mecanismo de morte associado a estas 
proteínas, após avaliar a atividade das caspases-3/7 e a presença de corpos apoptóticos, chegámos 
à conclusão que a apoptose poderá não ser a forma de morte celular predominante nestas condições 
experimentais.  
Em suma, os resultados obtidos são bons indicadores da presença de lectinas, na espécie 
estudada, sendo que a lectina purificada demonstrou capacidade de ligação e atividade antitumoral 
para as células HT29, não se confirmando, no entanto, um mecanismo por apoptose. Este resultado 
final não invalida que se prossiga com a purificação de outras lectinas, também presentes no extrato 
proteico desta espécie e posterior avaliação do seu efeito a nível das células tumorais, uma vez que 
outras proteínas, com diferentes pesos moleculares, nomeadamente ≈ 29 kDa e ≈ 50 kDa, presentes 
no extrato proteico do Arbutus unedo, se ligaram igualmente às membranas das células HT29. As 
diferentes frações proteicas obtidas durante a purificação de lectinas revelaram U.H. (unidade 
hemaglutinante) diferentes, tendo a fração não adsorvida à coluna Q-Sepharose uma U.H. menor 
que a fração não adsorvida à coluna Mono S. O extrato total apresentou melhores resultados ao 
nível da atividade antitumoral do que a lectina purificada. 
 
Palavras Chaves: Lectinas; cancro colon retal; glicosilação aberrante; apoptose; necrose 
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1. Lectins 
1.1. Definition  
Lectins are a group of highly diverse proteins (Silva et al., 2014), with non-immune origin, 
which bind in a reversible and specific manner to glycan and other molecules containing 
glycosylated receptors through hydrogen bonds and Van der Waals interactions (Lis and Sharon, 
1998; Vasconcelos and Oliveira, 2004). These proteins may be used to precipitate glycoconjugates 
(Goldstein et al., 1980; Van Damme et al., 1998). Furthermore, lectins have at least one non-
catalytic domain that enables them to selectively recognize mono-, poly- or oligosaccharides, and 
to bind without altering the structure of the glycan (Silva et al., 2013; Silva et al., 2014). 
The first lectin described was in 1888 by Hermann Stillmark, who observed the agglutination 
of erythrocytes, while studying the toxic effect of castor bean seed extracts (Ricinus communis L.) 
in blood (Stillmark, 1888). Since then, the word agglutinin has been extensively used to describe 
molecules with capacity to agglutinate erythrocytes and other cells (Hartley and Lord, 2004). Only 
in 1954 the term lectin (from the Latin verb legere, which means “to select”) was proposed by 
William Boyd (Boyd and Shapleigh, 1954; Lam and Ng, 2011) to referred to the ability of some 
carbohydrate-binding proteins to selectively agglutinate erythrocytes of a particular human blood 
group (Peumans and Damme, 1995). 
 
1.2. Occurrence of lectins 
Lectins are widely distributed in nature and can be found in almost all cells and secretome 
membranes of all living organisms, including plants, algae, fungi, animals (vertebrates and 
invertebrates), microorganisms and viruses (De Hoff et al., 2009; Faheina-Martins et al., 2012). 
In all tissues of plants, like leaves, stems, bark, bulbs, tubers, corms, rhizomes, phloem, fruits, 
roots and flower tissues we can found lectins, and due their specific carbohydrate binding they are 
able to recognize hormones, nucleic acids and non-protein amino acids (De Mejia and Prisecaru, 
2005). This characteristic and its great distribution in nature shows that lectins are very important 
selective proteins. 
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1.3. Biological role of plant lectins and their application 
Currently, lectins have become the focus of intense interest for biologists, in particular for the 
research and begins to be use in agriculture and medicine (Movafagh et al., 2013) due to their 
highly specific interaction with glycans and the associated biological effects. The idea that lectins 
and glycans are excellent as cell recognition and interaction markers, cell adhesion, migration and 
invasion, originates from the findings that both classes of compound are commonly present on the 
cell surface (Figure I.1) and that glycans possess tremendous coding capacity (Ambrosi et al., 2005; 
Ribeiro et al., 2012).  
 
 
 
 
Figure I.1 – Lectin binding to glycoconjugate promoting cell-cell interaction. 
Adapted from Nangia-Makker et al., 2002 
 
In plant, lectins play vital self-defending roles by deleteriously affecting the growth of insects 
or hindering oviposition behavior (Sadeghi et al., 2006). The vulnerable plant organs like seeds 
usually possess an abundance of lectins (Worbs et al., 2011). Expression of lectins in plants is 
sensitive to stress factors and environmental variations, like insect herbivory, drought, wounding, 
salt stress, hormone treatment and pathogen invasion (Zhang et al., 2000; Lannoo and Van Damme, 
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2010). Tobacco leaves normally express a very low level of lectin, however, when treated with 
jasmonates or threatened by insect herbivory, lectin expression was found to be upregulated (Chen 
et al., 2002; Lannoo and Van Damme, 2010). Plant lectins may also be involved in the interactions 
between plant and soil bacteria to establish a symbiotic relationship. For example, legume lectins 
contribute to the binding of rhizobia to the roots and formation of nodules (De Hoff et al., 2009), 
that have a better nitrogen fixation capacity. 
The plant lectins, in human cells, are well known to possess anti-tumor activity via programmed 
cell death (PCD), allowing to keep homeostasis. Several plant lectins such as mistletoe lectin 
(MLs), and ricin (RCA) have antiproliferative activity and induce apoptosis in cancer cells. 
However, other lectins such as Concanavalin A (ConA) and Polygonatum cyrtonema lectin (PCL) 
may result in cell death after internalization by autophagy or binding receptors that contain certain 
glycans on the surface of cancer cells (Fu et al., 2011). 
 
1.4. Classification 
Lectins are a highly diverse group of proteins that include several families of proteins that 
generally, differ for biochemical/physicochemical properties, molecular structure, the binding 
specificity to carbohydrates and biological activities (Loris, 2002; Gallegos et al., 2014). The 
classification of lectins in families is a challenge, however, of great importance, since it allows a 
better understanding of their functions. Thus, lectins, in general, can be classified based on binding 
specificity to the carbohydrate, in view of the monosaccharide to which exhibit higher affinity and 
considering the general structure; according to the recognition domains (RCD) for glycans and on 
the structure and evolutionary relationship. 
 
1.4.1. Classification based on carbohydrate specificity 
Lectins were initially classified, from a practical point of view, based on their specificity for 
different blood groups, taking into account the phenomenon of hemagglutination and subsequently 
the carbohydrate(s) identity that specifically binds to lectins provoking the inhibition of the 
hemagglutination (Rego et al., 2002). 
According to the monosaccharide ligand toward which lectins exhibit the highest affinity, 
Sharon (1998) classified lectins into several groups: 
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- Mannose/Glucose (group I) 
- Galactose/N-Acetylgalactosamine (group II) 
- N-Acetylglucosamine (group III) 
- L-Fucose (group IV)  
- Sialic acid (group V) 
- Specific lectin to complex oligosaccharides and polysaccharides 
However, this classification ignores mannose-6-phosphate and N-acetylgalactose-4-sulfate (Lis 
and Sharon, 1998; Ambrosi et al., 2005).  
 
1.4.2. Classification based on the structure 
As more lectins with diverse sugar-binding specificities were gradually identified and taking 
into account that different carbohydrate-binding motifs can recognize similar sugar structures, the 
old system was no longer feasible, and another classification system were proposed. 
Based on the overall domain structure of mature plant lectins, Van Damme and colleagues 
(1998), introduced another classification system in which they divided into four main classes: 
merolectins, hololectins, chimerolectins and superlectins (Van Damme et al., 1998). 
The merolectins are proteins that have only one binding domain glycans (Vasconcelos and 
Oliveira, 2004) consist of small individual polypeptides, because of their monovalent nature, are 
unable to agglutinate cells or precipitate glycoconjugates (Peumans and Damme, 1995). 
The hololectins comprise all lectins that have the glycan binding domains (Vasconcelos and 
Oliveira, 2004), are able to agglutinate cells and precipitate glycoconjugates. Obviously, most of 
all plant lectins subtypes are hololectinas, since they behave as hemagglutinin (Peumans and 
Damme, 1995). 
The chimerolectins are proteins consisting of one or more binding domains glycans with the 
addition of catalytic and biological activity, dependent on the different domain than the glycan 
binding (Vasconcelos and Oliveira, 2004).  
The superlectins at least have two glycan binding domains but differ of hololectinas because of 
their binding sites are capable of recognizing not structurally related sugar (Vasconcelos and 
Oliveira, 2004). 
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1.4.3. Classification based on the structure and evolutionary relationships 
More recently Van Damme and colleagues (2008) developed a new plant lectins classification 
system taking into account all the data that have become available in recent decades. According to 
the analysis of the genome/transcriptome plant lectins can be classified into 12 distinct families 
(Table 1) with domains evolutionarily and structurally related, such as (1) Agaricus bisporus 
agglutinin homologs, (2) Amaranthins, (3) Class V chitinase homologs with lectin activity, (4) 
Cyanovirin family, (5) EEA family, (6) GNA family, (7) Proteins with hevein domains, (8) 
Jacalins, (9) Proteins with legume lectin domains, (10) LysM domain, (11) Nictaba family 
(formerly Cucurbitaceae phloem lectins), (12) Ricin-B family (Van Damme et al., 2008; De Hoff 
et al., 2009; Fu et al., 2011). 
 
Table I-1 – The classification of plant lectins. Relation between structural and evolutionary characteristics 
and sugar-biding specificity classification. 
Representative lectin Abbreviation Family Sugar-biding specificity 
Agaricus bisporus agglutinin ABA Agaricus bisporus agglutinin 
homologs 
Galactose 
Amaranthins 
Chitinase-related agglutinin CRA Class V chitinase homologs 
with lectin activity 
High-mannose N-glycans 
Cyanovirin-N CV-N Cyanovirin family Mannose 
Euonymus europaeus agglutinin EEA EEA family Mannose/galactose 
Polygonaturn cyrtonema lectin PCL GNA family Mannose/sialic acid 
Wheat germ agglutinin WGA Proteins with hevein 
domains 
N-acetyl-D-glucosamine 
Jacalin JAC Jacalins Mannose 
Concanavalin A ConA Proteins with legume lectin 
domains 
D-mannose 
LysM domain 
Cucurbitaceae phloem lectin CPL Nictaba family 
European mistletoe lectin ML-I Ricin-B family Beta-galactose 
Adapted from Fu et al., 2011 
 
Recent studies show that previously reported carbohydrate-binding affinities are sometimes 
misleading for lectin classification, because lectins, as determined by glycoarray analyses, 
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generally show higher binding affinities to complex oligosaccharides than to simple 
oligosaccharides or monomers (Van Damme et al., 2008). For this reason, the traditional methods 
of carbohydrate monomer-based lectin classification are being supplanted by the more informative 
homology-based systems (De Hoff et al., 2009). Each lectin domain has its own characteristic 
overall fold with one or more carbohydrate-binding sites (Vandenborre et al., 2011). The 
occurrence of a particular carbohydrate-binding domain is in most cases not restricted to a certain 
plant family. Moreover, most of these domains are spread all over the plant kingdom (Jiang et al., 
2010). 
 
1.5. Molecular structure  
The structural studies of lectins, made by crystal structure, have shown that the different lectin 
families are generally structurally unrelated. Due to this fact, their recognition sites are highly 
variable, causing the different lectin families to exhibit different carbohydrate binding specificities 
(Loris, 2002). 
Lectins of leguminous plants are the group of plant lectins best studied and characterized. Lectin 
Concanavalin A (Con A, Figure I.2 and Figure I.3) belongs to this group and was the first lectin 
to have resolved its three-dimensional structure, so far, the lectin best characterized. Therefore, in 
this work in relation to the molecular structure Con A and this lectin family will receive greater 
emphasis. 
 
 
 
 
 
 
 
 
 
Figure I.2- Representative structure of Concanavalin A lectin. A – Con A fold, tertiary structure of a 
monomer. B – Dimerization in Con A. C – Association of two dimers, tetramerization in Con A. 
Adapted from Srinivas et al., 2001 
A B C 
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The legume lectins commonly consist of two or four 25–30 kDa subunits identical or almost 
identical, which are commonly single polypeptide chains of about 250 amino acids, and present a 
tightly bound Ca2+ and a transition metal ion, typically Mn2+ (Ambrosi et al., 2005; De Hoff et al., 
2009).  
In fact, these lectin family has very similar primary, secondary and tertiary structure. Almost 
60% of their secondary structure comprise of β-strands, connected to each other by loops. The 
tertiary structure is made up of two anti-parallel β-sheets, a six-stranded flat “back” and a seven-
stranded curved “front”, connect by a five-stranded β-sheet, this connection may be considered to 
form the “roof”, these structure has been described as to the “lectin fold” (Figure I.2.A), giving the 
well known the “jellyroll” motif (Srinivas et al., 2001; Ambrosi et al., 2005).  
Although there is about 20% conservation in amino acid residues, especially in those involved 
in the interactions with carbohydrates and in the coordination of metal ions, in particular those 
responsible for forming of the hydrophobic pocket (De Hoff et al., 2009), small changes in the 
sequence of the amino acids responsible for the monomer interface may occur. This fact together 
with the presence or absence of glycosylation seems to affect the association and organization of 
the monomers, resulting in different dimeric/tetrameric assemblage and consequently in quite 
different quaternary structures (Srinivas et al., 2001). 
In legume lectins with “canonical” quaternary association, for example Con A, the monomers 
interact extensively, involving a group of around 7 anti-parallel β-sheets that have a generally 
concave shape, one from each monomer. A considerable portion of the surface is buried in the 
process, a relatively large surface area, of about 1000 Å2 per monomer (Figure I.2.B). In 
physiological condition, the association of two dimers gives tetrameric assembly (Figure I.2.C) 
(Srinivas et al., 2001; Ambrosi et al., 2005). 
 
1.6. Mechanism of action 
Carbohydrates are a highly diverse group of molecules and each cell, plasma membrane, or 
intracellular organelle has a characteristic molecule of these group on the surface. The recognition 
process to the carbohydrates for a protein is a complex problem and involves a different type of 
forces and interactions. Since lectins can specifically recognize carbohydrates, these proteins are 
widely used as model systems for studying these interactions because they are relatively easy to 
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purify and they cover a wide range of carbohydrate specificities (Loris et al., 1998). This study’s 
is particularly interesting, since it provides the basis for understanding the proteins interactions 
with the natural ligands (Ambrosi et al., 2005).  
The mechanics of carbohydrate recognition by lectins have been studied by several techniques 
(Ambrosi et al., 2005), which allowed us to understand that although lectins are very different, they 
have structures with key characteristics shared by this class of proteins (Weis and Drickamer, 
1996). In relation to the binding sites for glycans, they are often superficial depressions on the 
surface of the protein, the combining site appears to be pre-formed, since some conformational 
change occurring upon binding (Ambrosi et al., 2005). 
Regardless of their specificity, all legume lectins have four invariable amino acids residues that 
are involved in ligand binding, they are: aspartic acid, asparagine, glycine and an aromatic amino 
acid or leucine (Imberty et al., 1994). However, different legume lectins can show different 
specificities, the specificity apparently arises from the variability of amino acid residues in other 
regions of the combined pocket (Ambrosi et al., 2005). 
The sugar combining site comprises amino acid residues residing in four loops, designated A, 
B, C and D (Young and Oomen, 1992). The invariant aspartic acid and glycine belong to A and B, 
respectively, while the asparagine and the hydrophobic residue are in loop C. The loop D is highly 
variable in terms of length, sequence and conformation and is responsible for additional 
interactions, suggesting a correlation between this circuit and the specificity of the lectin (Sharma 
and Surolia, 1997; Ambrosi et al., 2005). 
Although not always directly involved in glycan binding the cations Ca2+ and Mn2+ (or other 
transition metal) assist in the positioning of amino acid residues that interact with the glycoside. 
They are located around 4 Å apart and in close proximity to the sugar-combined pocket. The two 
invariant residues, aspartic acid and asparagine, are also involved in the coordination of Ca2+. A 
rare cisoid-peptide bond between the critical asparagine and the preceding amino acid, usually 
alanine, confers on the asparagine residue the proper orientation (Lis and Sharon, 1998; Ambrosi 
et al., 2005). 
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Figure I.3 – Concanavalin A ligand bind representation. A – Con A binding to alfa-D-mannose. B – Con 
A different folding according to the pH. 
Adapted from Fu et al., 2011  
 
The forces normally present in the binding of carbohydrates to lectins are hydrogen bonds and 
hydrophobic interactions. The Van der Waals forces contribute to this connection since they are 
often numerous (Lis and Sharon, 1998). The contact between the carbohydrates and lectins are 
often mediated by water molecules. The water acts as a molecular link that, because it is a small 
molecule capable of behaving both as donor and receptor of hydrogen, makes it nearly ideal for 
this function (Ambrosi et al., 2005). 
 
2. Colorectal cancer and cells glycosylation  
2.1. Colorectal cancer 
2.1.1. Epidemiology  
Colorectal cancer (CRC) is the third most commonly diagnosed cancer in males and the second 
most commonly diagnosed cancer in females. Worldwide in 2012 (Figure I.4), the most recent 
year for which WHO statistics are currently available, occurred 1.361 million new CRC cases and 
694,000 CRC related deaths (Ferlay et al., 2015).  
 
 
 
A B 
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Figure I.4 – Cancer geographic distribution. A - Worldwide incidence of all cancer (2012): colorectal 
cancer represents approximately 10% of all incident cancer, with a large geographic difference in the global 
distribution, nearly 55% of the cases of CRC occur in more developed regions. B - Geographical incidence 
of CRC variation across the world (2012), high rates in Australia, New Zealand, United States and Western 
Europe, with the lowest in Africa and some parts of Asia. 
Adapted from Ferlay et al., 2015 
 
There are several risk factors considered to be causally associated with the development of CRC, 
which can be divided in two categories, the nonmodifiable risks factors, that includes age (more 
than 90% of CRC cases occur in people aged 50 or older), some hereditary factors as, personal 
history of adenomatous polyps, personal history of inflammatory bowel disease, family history of 
A 
B 
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colorectal cancer (which represent 25% of the cases (Jorgensen et al., 2015)), adenomatous polyps 
(FAP) or inherited genetic risk; and environmental risk factors, these are also important in the 
development of this disease but can be modifiable, comprises: diets high in fat, physical inactivity 
and obesity, cigarrete smoking and heavy alcohol consumption (Haggar et al., 2009). 
 
2.1.2. Diagnosis and treatment 
The principal problem of CRC is because this cancer type is often asymptomatic in the first 
years causing is detection only in stage IV, which reduces the 5-year survival for 13%, when 
compared to patients who are diagnosed at stages I-II, when the treatments are often curative (Holst 
et al., 2016). This reveals a need for urgent biomarkers to early diagnostic. 
Current treatment is typically by surgical resection and systemic therapy using cytotoxic and 
target agents and radiotherapy to improve survival (O'neil and Goldberg, 2008; Stein et al., 2011). 
However, despite the advances in new therapies approximately 30% of patients has recurrence 
(Marin et al., 2012).  
 
2.1.3. Molecular modification and progression of CRC 
This type of cancer results from the progressive accumulation of genetic and epigenetic 
alterations that lead to the transformation of normal colonic epithelium, lining the large intestine 
(colon and rectum), to adenomas (Grady and Carethers, 2008; Cooper et al., 2010), and later to 
adenocarcinoma (Figure I.5). In these pathological modifications three main molecular pathways 
are involved, namely: genetic instability and aberrant DNA methylations by mutations in mismatch 
repair genes (MMR); mutational inactivation of tumor suppressor genes; and over activation of 
oncogenic pathways (Grady and Carethers, 2008). 
Metastasis represents the final step in CRC progression and involves migration, invasion, 
resistance, extravasation into the liver and/or lung, and angiogenesis (Valastyan and Weinberg, 
2011). This final step depends on two signalling pathways: the vascular endothelial growth factor 
(VEGF) and the epidermal growth factor receptor (EGFR) pathways (Aghagolzadeh and Radpour, 
2016).  
Phenotypic changes also occur due to post-translational modifications, namely, modifications 
in protein glycosylation, more specifically in N-glycosylation. N-Glycans are of extreme 
importance in the tumor process, since they are involved in several cellular mechanisms, such as 
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metabolization, signaling, growth, cell adhesion, cell-matrix interaction, invasion and metastasis 
(Figure I.5), all of these changes lead to the process progression of the disease (De Freitas Junior 
and Morgado-Diaz, 2016). 
 
 
 
 
 
 
 
Figure I.5 – Schematic representation of colorectal tumor progression. This is a multistep process where 
phenotypic changes are involved, namely changes in N-glycans. In the early stages, cell adhesion is 
mediated by E-cadherins, a stable phenotype, however the expression of branched N-glycans, induced by 
N-acetlyglucosaminyltransferase V (MGAT5), produce an unstable phenotype. 
Adapted from De Freitas Junior and Morgado-Diaz, 2016 
 
• Bisected 
• Branched 
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2.2. Aberrant glycosylation in cancer  
2.2.1. Glycosylation overview 
Glycosylation is the most frequent post-translational modification of proteins, structurally 
diverse and more common, and is involved in many essential functions for cell survival (Huang et 
al., 2014). The combined action of various enzymes (glycosyltransferases and glycosidases) leads 
to diverse glycan structures, wherein, the N and O glycosylation are the two glycosylation forms 
most prominent (Faheina-Martins et al., 2012; Decker et al., 2014). Changes in this process lead 
to aberration in glycosylation profiles, and seems to be correlate with the development of cancer 
and other disease states (Sunderic et al., 2015). The lectins due to it glycan specificity can be used 
as a decoding tool at aberration of cellular glycome. 
 
Glycans are molecules that have the ability to exist in different isomeric forms that yield a 
variety of branching structures. The complex structures that result from building complex glycans 
from simple sugars conjugate to a large range of biological molecules such as lipids, proteins, and 
cell surfaces which generate an array of biological selectivity (Patwa et al., 2010).  
Protein glycosylation is the most frequent modification, structurally diverse and more common, 
and is involved in many functions (Huang et al., 2014), such as, cell-cell signaling, protein stability, 
protein solubility, interaction of the ligands with the receptors (Yang et al., 2013), growth, 
differentiation, development, cell division, cell death, the immune response, cancer cell 
camouflaging, pathogens homing in on host cells, injury and inflammation (Patwa et al., 2010).  
Glycosylation is a common post-translational modification of secretory proteins and 
membrane-anchored lipids which become altered this way when passing through the lumen of the 
endoplasmic reticulum and Golgi apparatus (Rabinovich and Croci, 2012). Gene products that 
participate in oligosaccharide biosynthesis account for up to 1% of the translated genome. Of post-
translational modifications (PTM), only phosphorylation occurs to a similar magnitude as 
glycosylation (Patwa et al., 2010). 
The machinery of glycosylation is responsible for assembling the abundant and diverse 
repertoire of glycan structures, which collectively is called glycome, through the synchronized 
action of glycosidases and glycosyltransferases enzymes. Each of these glycosyltransferases 
structure uses a single nucleotide and form a specific bond between a monosaccharide and a glycan 
precursor (Rabinovich and Croci, 2012). 
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The combined action of the various enzymes leads to diverse glycan structures. These can exist 
either as free forms or conjugated to proteins and lipids (Figure I.6) and include: (1) glycoproteins 
with complex and branched N-linked glycans and/or with O-linked glycans that are abundant on 
mucins (Padler-Karavani, 2014); (2) glycosylphosphatidylinositol (GPI)-anchored proteins (share 
a common membrane-bound glycolipid linkage structure that is attached to various proteins) 
(Kinoshita et al., 1997; Padler-Karavani, 2014); (3) glycosaminoglycans (GAGs) either as linear 
free polysaccharides (such as hyaluronan) or attached to Serine residues of proteoglycans (such as 
heparin sulphate and chondroitin sulphate) (Esko and Selleck, 2002; Padler-Karavani, 2014); and 
(4) glycolipids, which consist of glycans linked to ceramide and that include the sialic acid-bearing 
gangliosides (Maccioni et al., 2002; Padler-Karavani, 2014).  
 
 
Figure I.6 - Schematic representation of glycoconjugates classes expressed in human cells.  
Adapted from Padler-Karavani, 2014 
 
The N and O glycosylation are the two forms of glycosylation most prominent. The N-glycans 
are conjugated to proteins via asparagine residues in a consensus 3 peptide sequence Asn-X-
Ser/Thr, where X is any amino acid except proline and the third amino acid can be serine or 
threonine (Faheina-Martins et al., 2012; Decker et al., 2014). These residues may be enzymatically 
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released from the protein using N-glycosidases (PNGases). The O-glycosylation of proteins occurs 
in both residues serine and threonine, and in this case, there is no specific enzyme comparable to 
PGNase to remove the intact O-glycans link to this end, chemical methods such as β-elimination, 
are generally used to deliver certain types of O-glycan peptides or proteins (Faheina-Martins et al., 
2012). 
In addition to cell surface glycans, nuclear and cytoplasmic proteins can be modified with O-
linked N-acetylglucosamine (O-GlcNAc; conjugated to serine) (Padler-Karavani, 2014). O-
GlcNAcylation occurs in the cytoplasm and modifies intracellular proteins, regulating their activity 
together with phosphorylation (Varki and Sharon, 2009).  
 
 2.2.2. Abnormal modifications of glycosylation 
One of the alterations that occur in cancer cells is in the profile of cell surface (Lahm et al., 
2004), particularly, modifications in glycosylation. The associated structural changes that 
accompany these aberrations can alter the antigenic and adhesive properties of tumor cells, their 
potential to invade peripheral tissues, and their capacity to metastasize (Hakomori, 2002; 
Kobayashi et al., 2007; Cho et al., 2010). In fact, the majority of cancer deaths are attributed to the 
metastatic spread of cancer cells to vital organs rather than to the primary tumor outgrowth 
(Hauselmann and Borsig, 2014). During malignant transformation, the genetic alteration in the 
cells results in mutations of proto-oncogenes and tumor suppressor genes, which as a result give 
rise to tumor clones with different properties (Hanahan and Weinberg, 2011). Malignant cells 
thereby acquire characteristics enabling them dissociation from tumors, degradation of the 
extracellular matrix, invasion, adhesion, and metastasis to distant organs (Hauselmann and Borsig, 
2014). 
 
In general, a shift from the normal glycosylation pathway leads to altered glycan expression due 
to one or more of the following changes: (1) under or overexpression of glycosyltransferases 
deregulated at the level of epigenetics (Miyazaki et al., 2004; Kannagi et al., 2008), transcription 
(Le Marer et al., 1992; Buckhaults et al., 1997; Hatano et al., 2012; Jun et al., 2012), post-
transcription (Kim et al., 2013) and/or chaperone (Schietinger et al., 2006); (2) altered glycosidase 
activity (Hakomori, 2002; Kakugawa et al., 2002; Miyagi et al., 2004; Miyagi et al., 2012); (3) 
altered expression of glycoconjugate acceptor together with availability and abundance of the 
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sugar nucleotide donors (Dennis et al., 1987); (4) altered sugar nucleotide transporter activity 
(Kumamoto et al., 2001); and (5) improper function of the Golgi structure (Kellokumpu et al., 
2002) where many of the glycosyltransferases are harbored (Moremen et al., 2012). 
 
In this process, a variety of molecules are involved, including various key cell surface proteins 
that bear complex N-glycan arrays, in particular, distinct changes of sialylation and sialylated 
structures.  
The β-galactoside α 2, 6-sialyltransferase (ST6 Gal I) is one of the glycosyltransferases that 
belongs to sialytransferases family, which are key enzymes in the biosynthesis of sialic acid-
containing glycoproteins and glycolipids (Park and Lee, 2013). The ST6 Gal I has been shown to 
be critical to the development of colorectal cancer (Dall'olio et al., 2006; Swindall and Bellis, 2011; 
Swindall et al., 2013). Indeed, the upregulation of this sialyltransferase is probably the basis for 
increased α 2, 6 sialylation seen in CRC cells, positively correlated with metastasis and poor 
prognosis (Park and Lee, 2013). 
 
2.2.3. Glycosylation modification in cancer 
Cancer encompasses a cluster of diseases involving changes in the status and expression of 
multiple genes, by transforming normal cells into malignant cells, which eventually invade 
neighboring or distant tissues. These changes confer advantages to tumor cell survival and 
proliferative potential allowing expression of uncontrolled growth signals, thus making the 
inhibitory effects of tumor suppressor genes irrelevant. 
As previously mentioned, one of the alterations that occurs in cancer is in the profile of cell 
surface (Lahm et al., 2004), particularly, modifications in glycosylation (Figure I.7). Among the 
most common changes on carcinoma cells are the increase of N-glycans and the sialic acid content 
in the cell surface, the abnormal production of mucin, expression of Lewis x/a structures in 
glycosphingolipids, and the increased expression of galectins (Table I.2) (Hauselmann and Borsig, 
2014). 
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Figure I.7 – Representative glycans involved in tumor progression. 
Adapted from Fuster and Esko, 2005 
 
Table I.2 – Common glycan alterations on carcinoma cells. 
Structural change Carries 
Biosynthetic basis of structural 
change 
Increased β1,6-branching (N-
linked) 
N-glycans Increased GnT5 
Increased α2,6-sialylation N-glycans, e.g., β-integrin 
Increased ST6Gal1 
sialyltransferase 
General increase in sialylation Mucins N-glycans 
Increased sialyltransferase 
activity 
Increased sialyl-Lewisx/a Mucins 
Increased FUT7, FUT3, FUT6, 
ST3Gal6 
Decreased di-sialyl-Lewisx/a Mucins, glycolipids 
Decreased 
ST6GalNAc6GlcNAc6ST1 
Increased Tn epitopes 
Mucins (e.g., MUC1), CD44, β1 
integrin, osteopontin 
Downregulated T-synthase 
activity due to Cosmc mutations 
Increased sialyl-Tn epitopes 
Increased ST6GalNAc1 
expression 
Increased T antigen (core 1 
structure) 
Decreased C2GnT2 
Enhanced availability og UDP-
galactose 
Increased sialyl-T antigens 
Increased levels of α2,3-
sialyltransferase (ST3Gal1) 
Adapted from Hauselmann and Borsig, 2014 
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The structural changes that lead to these aberrations can modify the tumor cells at the level of 
their adhesion and of antigenic properties, this makes it have the capacity to invade the peripheral 
tissues and the capacity to metastasize (Hakomori, 2002; Kobayashi et al., 2007; Cho et al., 2010). 
In fact, metastasize for vital organs is the most responsible for cancer-related deaths (Hauselmann 
and Borsig, 2014). During malignant transformation, the genetic alteration in the cells results in 
mutations of proto-oncogenes and tumor suppressor genes, which consequently give rise to tumor 
clones with different properties (Hanahan and Weinberg, 2011). Malignant cells thereby acquire 
characteristics enabling their release from tumors, degradation of the extracellular matrix, invasion, 
adhesion, and metastasis to distant organs (Hauselmann and Borsig, 2014). 
 
Altered branching of N-glycans 
The N-glycan biosynthesis and their products can be involved in several mechanisms in cancer 
progression. Some possible mechanism(s) by which these biochemical and structural changes 
result in the biological outcomes observed include: 
- The length of N-glycans or the number of N-glycosylation sites, these interfere with the cell-
cell adhesion mediated by E-cadherin (De Freitas Junior and Morgado-Diaz, 2016);  
- The β1,6 branched and bisected N-glycan, these modulate cell behavior by interfering in the 
physical and performance properties of glycosylated adhesion molecules on the cell surface, such 
as the integrins, and signaling receptors, such as the T-cell receptor and cytokine receptors (Varki 
et al., 2009; De Freitas Junior and Morgado-Diaz, 2016); 
- The upregulation of α2,6-sialylated lactosamine modulates invasiveness and stemness (De 
Freitas Junior and Morgado-Diaz, 2016), these feature was also responsible for therapeutic 
resistance in CRC (Park and Lee, 2013); 
- An increase in poly-N-acetyllactosamine-containing glycans, potentially recognized by 
galectins, that are preferentially found on this β1–6 branch (Varki et al., 2009);  
- Modifications in the cell-surface half-life of growth factor receptors caused by changes in 
galectin-mediated lattice formation (Varki et al., 2009);  
- The increased outer-chain polyfucosylation and sialyl Lewisx production (potentially 
recognized by the selectins) (Varki et al., 2009);  
- A general biophysical effect of the branching itself on membrane protein structure (Varki et 
al., 2009).  
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The increased size of tumor cell–derived glycopeptides is due an increase in β1–6 branching of 
N-glycans (Figure I.8), these results from enhanced expression of UDP-GlcNAc:N-glycan 
GlcNAc transferase V (GlcNAcT-V). The viral and chemical carcinogenesis may be responsible 
for the increased transcription of gene MGAT5, that affect modifications in expression of this 
enzyme GlcNAcT-V (Varki et al., 2009; Hauselmann and Borsig, 2014). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure I.8 – The GlcNAc transferase-V (GNT-V) increase activity can explain the increased size of N-
glycans that occurs upon transformation. 
Adapted from Varki et al., 2009 
 
Altered branching of O-glycans 
Abnormal O-glycans expressed by cancer cells have functional importance in cell adhesion, 
invasion and metastasis (Baldus et al., 2004). In particular, an incomplete elongation of O-glycans 
in mucins (Figure I.9), that are large glycoproteins with a “rod-like” conformation, which carry 
many clustered glycosylated serines and threonines in tandem repeat regions (Varki et al., 2009), 
lead to the expression of shortened carbohydrate structures, such as the Tn (αGalNAc-O-Ser/Thr), 
sialyl-Tn (αNeuAc2,6-αGalNAc-OSer/Thr) or TF (βGal1,3-αGalNAc-O-Ser/Thr) antigens 
(Osinaga, 2007).  
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These structures, are very important since they have particular features, important in cancer 
biology. They can be excellent diagnostic markers, they are related to the aggressiveness of the 
tumor, the more antigens are the more aggressive is the carcinoma (for example, TF antigens 
interacts with galectin 3, and this interaction is involved in the cellular adhesion of some cancer 
cells) (Osinaga, 2007) and can be processed by T cells and presented by the major 
histocompatibility complex eliciting thereby specific immune responses (Werdelin et al., 2002).  
A number of factors can influenced the mucin-type O-glycosylated antigens expression, for 
example: the availability of functional ppGalNAc-Ts, the amino acid sequence environment, post-
translational modifications of the peptide substrates, and/or  the availability of glycosyltransferases 
(Osinaga, 2007). 
 
Figure I.9 – Biosynthesis scheme of O-glycans.  
Adapted from Hauselmann and Borsig, 2014 
 
Altered sialic acids expression 
The surface properties of cancer cells are different than those of normal cells and one of the 
things that contribute to that phenotypic change are the sialic acids. Sialic acids (Sia) are nine-
carbon backbone α-keto acidic sugars, that at physiological pH has the carboxylate groups 
negatively charged. Modifications in Sia level, linkage, distribution and increased activity of 
sialyltransferases are associated with various aspects of malignant transformation and promote 
metastic potential (Padler-Karavani, 2014). 
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As previously mentioned, the most common aberrant glycosylation in cancer are in N-glycans, 
like, the increased activity of the β1-6GlcNAc branching enzyme, GlcNAc-TV or MGAT5, that 
lead to larger and more branched N-glycans providing additional acceptors for terminal sialylation. 
These changes together with the increase expression of sialyltransferases, contributes to cell 
surface sialylation and metastatic potential. 
On the other hand, the aberrant O-linked glycosylation can also lead to increased sialylation, the 
overproduce mucins (that are heavily glycosylated glycoproteins, characterized by dense clusters 
of O-glycans) produce cancer-associated to mucin-type O-glycans and tend to be truncated due to 
a shift in the normal enzymatic machinery and are usually highly sialylated and less sulphated 
(Padler-Karavani, 2014). 
 
3. Cellular death mechanisms and lectins as antitumoral agents 
3.1. Cell death mechanisms 
Cell death can be classified into: “accidental” and “regulated”. Accidental cell death (ACD) is 
caused by severe insults, including physical, chemical and mechanical stimuli, is insensitive to 
pharmacologic or genetic interventions of any kind and includes cell death of the necrotic type. On 
the other hand, regulated cell death (RCD, include programmed cell death (PCD), comprise 
apoptosis, autophagy, necroptosis and lysosomal-mediated  cell death (Kreuzaler and Watson, 
2012)), can be altered by means of pharmacologic and/or genetic interventions targeting the key 
components of such a machinery, and involves a genetically encoded molecular machinery 
(Galluzzi et al., 2015).  
 
3.1.1. Accidental cell death 
Necrosis is a kind of death in which cells undergo an increase in cell volume, chromatin 
aggregation, disruption of cytoplasm, loss of plasmatic membrane integrity and subsequent cell 
disruption. During necrosis, cellular contents are released, causing damage to surrounding cells 
and an inflammatory reaction on the local (Ziegler and Groscurth, 2004). More recently, regulated 
necrosis or necroptosis has also attracted much attention as a specific signaling pathway amenable 
to therapeutic targeting (Galluzzi et al., 2015).  
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3.1.2. Programmed cell death 
Apoptosis is a complex but highly defined cellular program of cell death, tightly regulated by 
multi-step pathway that is responsible for cell death not only during development, but also in adult 
multicellular organisms, in which it partly controls cell balance. It is characterized by cell 
shrinkage, chromatin condensation, and nuclear and cell fragmentation. These features result in the 
formation of apoptotic bodies that are then engulfed by neighboring phagocytic cells (Cotter, 
2009). 
The mechanism of apoptosis requires the interplay of numerous factors such as caspases (Saraste 
and Pulkki, 2000). Fourteen human caspases are known and six of them (caspases -2, -3, -6, -7, -
8, -9, -10) are involved in apoptosis. Caspases cleave substrates with aspartate residues leading to 
condensation, nuclear fragmentation and externalization of membrane phospholipids. This will 
signal that these cells are to be phagocytosed by macrophages (Nicholson and Thornberry, 1997; 
Boatright and Salvesen, 2003).  
p53 is often regarded as the "guardian of the genome" (Lane, 1992) as it exerts tumor suppressor 
capabilities through central coordination of a regulatory circuit that monitors and responds to a 
variety of stress signals, including DNA damage, abnormal oncogenic events, erosion of telomeres, 
hypoxia and ribosomal stress (Kruse and Gu, 2009; Luo et al., 2013; Hao and Cho, 2014). 
However, under normal physiological conditions, p53 is maintained at low intracellular 
concentrations through its negative regulator, Mdm2, which targets the degradation of p53 by 
ubiquitin-dependent proteasome (Carvajal and Manfredi, 2013). 
The activation of apoptosis can be initiated in two different ways: the extrinsic pathway 
(cytoplasmic) or the intrinsic pathway (mitochondrial), and these two ways are interconnected. The 
extrinsic pathway is triggered by the binding of specific ligands to death receptors (DR), which 
allows the activation of the caspase cascade. Effector caspase activation by initiator caspases leads 
to cleavage of the substrate starting the morphological changes and leading to cell death. These 
substrates are proteins that belong to various functional classes including: apoptosis signaling 
proteins (eg IAPs, Bcl-2); protein kinases (eg FAK, PKC); structural/cytoskeletal proteins (eg 
gelsolin, lamin); cell repair proteins (PARP, ATM); and cell cycle proteins (eg p21, Rb, p27). Most 
proteins are inactivated following caspase cleavage and some are activated. 
The intrinsic pathway is activated by intracellular or extracellular stress as lack of growth 
factors, DNA damage, hypoxia, oncogene activation and as a result of extrinsic pathway activation. 
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Mitochondria are the principal mediators of such cell death stimuli. When death signals reach 
mitochondria, they lead to collapse of mitochondrial inner membrane potential and rupture of the 
organelle. Consequently, pro-apoptotic proteins are released, which leads to loss of cellular 
homeostasis, disruption of ATP synthesis and increased production of reactive oxygen species. 
Caspase activation by DR is suppressed by FLIP, a master anti-apoptotic regulator and 
resistance factor that suppresses tumor necrosis factor-α (TNF-α), Fas-L, and TNF-related 
apoptosis-inducing ligand (TRAIL)-induced apoptosis, as well as apoptosis triggered by 
chemotherapy agents in malignant cells. Induction of the DR pathway, which results in the 
activation of caspase-8 can lead directly to the activation of caspase-3 without the need for 
mitochondrial damage. Alternatively, it may involve Bid, resulting in the potential loss of 
mitochondrial membrane and release of cytochrome c into the cytoplasm. Cytochrome c in the 
presence of ATP and Apaf1 activates caspase-9, which results in the activation of caspase-3. The 
anti-apoptotic molecules Bcl-xL and Bcl-2 protect against loss of mitochondrial membrane 
potential that is induced by pro-apoptotic molecules such as Bax and Bak. 
 
Autophagy is an evolutionarily conserved and adaptive process under genetic control. This 
occurs in response to metabolic stress that results in the degradation of cellular components (Lum 
et al., 2005). In many tumors, the autophagic cell death mechanism is usually hiper-activated and 
inhibition can lead to increased death or survival depending on the cancer type (Kreuzaler and 
Watson, 2012). 
During autophagy, cytoplasmic portions are encapsulated by cell membranes, resulting in 
structures called autophagosomes. These will merge with lysosomes and the contents of 
autophagosomes will be degraded by lysosomal hydrolases (Kelekar, 2005). The genes that codify 
proteins (ATG genes) involved in autophagosome formation are tightly regulated (Klionsky, 2007), 
showing the importance of the complex. The Atg proteins, including ATG5, ATG7, ATG4B, and 
LC3, are involved in the fusion of the secretory lysosomes with the plasma membrane and 
subsequent formation of the ruffled border. The LC3 promotes the phagosomes fusion with 
lysosomes leading to a rapid acidification (Reggiori, 2012). 
 
Necroptosis is a death mechanism that has necrotic phenotype but can be regulated. The 
necrotic phenotype can be explained by the absence of caspase activation, particularly caspase-8. 
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This cell death type is dependent on the activity of the death domain (DD)-containing kinase RIP1, 
which is essential for the execution of the necroptotic programme (Kreuzaler and Watson, 2012). 
 
3.2. Some lectins with antitumoral effect 
Since lectins are excellent proteins capable of cell recognition by glycans binding, some plant 
lectins are used as simple tumor recognition tools, in diagnosis and prognosis, to differentiate 
malignant tumors from benign and the degree of glycosylation associated with metastasis (Gupta 
et al., 2010). In addition, some lectins also possess antitumor activities, via targeting programmed 
cell death (PCD) (Fu et al., 2011). 
Several plant lectins such as Mistletoe lectins (MLs) and Ricin have been well-studied to possess 
antiproliferative and apoptosis-inducing activities toward cancer cells (De Mejia and Prisecaru, 
2005). Besides, other lectins such as ConA and PCL can result in autophagic cell death after 
internalization or binding certain sugar-containing receptors on the surface of cancer cells (Lei and 
Chang, 2007). 
Following are some examples of plant lectins that lead to programmed death via targeting 
apoptotic and autophagic pathways in various types of cancer cells.  
 
3.2.1. Molecular mechanisms of Mistletoe Lectins (MLs) 
The Mistletoe lectins (MLs) are divided into three distinct types, namely, ML-I, ML-II and ML-
III with therapeutically activity. These lectins show different specificity, being the ML-I with D-
galactose specificity and ML-II and ML-III preferentially bind to N-acetylgalactosamine (Bantel 
et al., 1999). MLs lectins are well-studied type II ribosome inactivating proteins (RIPs II), inhibin 
the intracellular protein synthesis via interacting with 28S ribosome, also they have 
antiproliferative and apoptosis-inducing mechanisms (Figure I.10) in cancer cells (Bantel et al., 
1999; Seifert et al., 2008).  
The ML-I can induce apoptosis by extrinsic apoptotic pathway activating and subsequently to 
caspase 8, through TNF-family death receptors in determining cancer cell death. In some types of 
cells cancer ML-I induces apoptosis by the breakdown of mitochondrial membrane potential 
leading to cytochrome c release and increase of the levels of reactive oxygen species (ROS) and 
caspase-3 activation independently of p53, but apoptosis-associated factor-1 (Apaf-1)-dependent 
pathway (Hostanska et al., 2003).  
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The ML-II can activate MAPK signaling, implicated in ERK and p38, this can modulated the 
signaling pathways that lead to anti-proliferative and apoptosis inducing activities (Fu et al., 2011). 
This protein can also induce apoptosis via activating SAPK/JNK and p38 pathways, as well as via 
inhibiting ERK1/2 pathway in human monoblastic leukemia U937 cells (Pae et al., 2001). 
 
3.2.2. Molecular mechanisms of proteins with legume lectin domains (Con A) 
Proteins that possess legume lectin domains have a wide range of biological functions such as 
antitumor, anti-viral, and anti-fungal activities. Concanavalin A, that can be extracted from Jack 
bean (Canavalia ensiformis) seeds, is a mannose/glucose-binding lectin legume with apoptosis-
inducing activities (Figure I.10), that can be mediated by mitochondria mediated apoptotic 
pathway (Fu et al., 2011; Yau et al., 2015), mitochondrial membrane potential collapse, 
cytochrome c release and caspase 9/3 activation.  
This lectin has been widely studied since the observation of cell death mechanism.  One of the 
molecular mechanism that Con A can induce cellular death is by autophagic via BNIP3 (pro-
apoptotic protein) in hepatoma cells (Hannigan and Gorski, 2009). Con A binds to mannose residue 
in cells membranes and is internalized to the mitochondria surface resulting a reduction in the 
mitochondrial membrane potential. LC3-II protein formation is related to BNIP3 and beclin-1 
proteins induction. The BNIP3 determine the state of permeability of the mitochondrial pores 
(Chang et al., 2007). In these process were also detected double-layer vesicles and acidic vesicular 
organelle (Li et al., 2010). 
Another study has also shown Con A capacity to induce apoptosis regulated by autophagy in 
HeLa cells (Roy et al., 2014). Usually, the phosphatidyl-inositol 3-kinase/Akt/mammalian target 
of rapamycin (PI3K/Akt/mTOR) pathway is activates and the Raf/MEK/ERK pathway is inhibited 
in cancer cells. The Con A treatment in HeLa cells reduce Akt phosphorylation and mTOR activity, 
showing that Con A has the capacity to downregulated the PI3K/Akt/mTOR pathway and 
upregulated the MEK/ERK pathway (Roy et al., 2014), leading to autophagy in these cells. 
 
3.2.3. Molecular mechanisms of Galanthus nivalis agglutinin (GNA) family 
Polygonatum cyrtonema lectin (PCL), a mannose/sialic acid-binding lectin from GNA family, 
has been study for its role in cancer cell death targeting PCD pathways (Figure I.10), as apoptosis 
and autophagy. These lectin can induce these two types of cell death and they are connect with 
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each other to participate in leading to cancer cell death via promoting a mitochondria-mediated 
ROS-p38-p53 pathway (Liu et al., 2009), as well as via blocking Ras-Raf and PI3K-Akt pathways 
(Wang et al., 2011). 
Polygonatum odoratum lectin (POL), another lectin from GNA family has also been described 
with capacity to induce cell death by apoptosis and autophagy by targeting epidermal growth factor 
receptor-mediated Ras-Raf-MEK-ERK signaling pathway. Also, these lectin shows apoptosis 
selectivity for lungs cancer cells but not for healthy lung cells (Yau et al., 2015). 
 Figure I.10 - Plant lectins induce cancer cell death via targeting programmed cell death (PCD) signaling 
network. 
Adapted from Fu et al., 2011 
 
After the general review of the different cancer cell death mechanisms by plant lectins described 
so far, we can conclude that there are three hypotheses for lectins to induce death in cancer cells: 
directly interfering in the ribosome of cancer cells, to inactivate it; after endocytosis, selective 
binding to certain organelles, such as mitochondria; and binding to receptors that contain sugars 
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on the cells surface, this being of paramount importance since these receptors are often exclusive 
of cancer cells, making this binding quite selective (Fu et al., 2011).  
The study of glycosylation profiles changes can be carried out by using lectins, since these have 
determinant regions that allow unique specificity for a particular glycan and generally do not 
interfere with the protein structure. They are also able to interact with several molecules of 
biological fluids and cell surface receptors, acting as decoding of information exchanged between 
molecules, cells or organisms. This possible application of lectins, opens the way for the early 
diagnosis and treatment, where lectins may be used as therapeutic agents (Table I.3) or as drug 
vehicle. 
 
Table I.3 – Examples of lectins with antitumor potential known, the cell lines affected by each lectin and 
some of the known mechanisms involved. 
Lectin Cancer Cell Lines Affected Effector Mechanism(s) 
Galectins Epidermal keratinocytes, 1299 lung 
cells, fibroblast cells, thyroid cell, 
colon cells 
T-cell binding, specific integrin 
binding, Ca2+-calpaincaspase-1 
pathway 
C-Type Lectins SW1116 colorectal cells Le glycan recognition, perforin 
granzyme pathway, TRAIL and 
FAS lingand binding 
Annexins Melanoma cells, lung cells NF-κB signal transduction 
pathway, Ras-Raf-MAPK 
pathway, p53 apoptotic pathway 
Sialic acid binding Haliotis 
discus discus lectin 
(HddSBL) 
Hep3B hepatocellular cells, SW480 
colorectal cells, A549 and H1299 
lung cancer cell line cells 
Bcl-2 down-regulation 
Polygonatum odoratum 
lectin (POL) 
A549 lung cells, L929 murine 
fibrosarcoma cells 
Akt-mTOR pathway, Fas 
mediating apoptotic pathway, 
TNFα enhancement 
Mistletoe lectin Hepatocarcinoma cells, breast 
cancer cells, NALM-6 acute 
lymphoblastic leukemia cells, 
glioblastoma cells, 
hepatomacarcinoma cells, 
peripheral blood mononuclear cells, 
A253 epidermoid cells 
Wnt signaling miR-135a and b, 
NK-mediated cell lysis, 
interleukin mRNA activation 
Concanavalin A (ConA) A375 and B16 melanoma cells, 
fibroblast 3T3 cells, colorectal 
cancer cells 
Mitochondrial apoptotic 
pathway, caspase induction 
Adapted from (Yau et al., 2015). 
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The antitumor effect of lectins in a cell line of human colorectal cancer, HT29 cells, has been 
demonstrated and several mechanisms of action have been proposed. These include binding to cell 
membrane (Nunes, 2014), cytotoxicity (Amaranthus caudatus) and tumor inhibition (Artocarpus 
integrifolia), as well as inhibition of proliferation (Sauromatum venosum, Arbutus unedo, 
Juniperus oxycedrus var. badia) (Castillo-Villanueva and Abdullaev, 2005) and MMP-2 and 
MMP-9 activity inhibition (Nunes, 2014). 
 
4. New lectins in Mediterranean flora as therapeutic tools for cancer 
Since ancient times the plants are widely used due to it’s curative and preventive capabilities 
and it’s high content of bioactive principles, being a valuable source of therapeutic agents. The 
WHO estimates that traditional medicine, mostly plant-derived drugs, is responsible for the health 
care of 80% of the world population. Given these facts, it is no surprise that the study of potential 
medicinal plants and their bioactive compounds have, today, huge relevance. 
Here are some examples of species of Mediterranean flora that were studied due to it’s high 
content in bioactive compounds, thus giving them preventive and healing properties in several 
pathologies. Generally, the bioactivities described have been attributed to various classes of active 
principles, with special relevance to the phenolic compounds and alkaloids. The study of lectins 
has been relegated to the background. For it’s antitumor mechanism of action and by the fact that 
the plants are an excellent reservoir of lectins, we consider to be promising it’s evaluation in species 
with pharmacologic properties already described. 
 
4.1. Arbutus unedo L. 
Arbutus unedo L. is a small evergreen tree that belongs to the Ericaceae (Carcache-Blanco et 
al., 2006). This strawberry tree thrives on the Iberian Peninsula and in the Mediterranean basin, as 
well as in other regions with hot summers and mild rainy winters. The spherical fruits with a 
diameter of about 2–3 cm are red and tasty only when fully ripe. The fruits are edible but usually 
processed before consumption (Oliveira et al., 2009). 
The fruits contain several antioxidant molecules namely phenolic compounds (e.g. 
anthocyanins, gallic acid derivatives, tannins and flavonoids), vitamin C, vitamin E and carotenoids 
(Oliveira et al., 2009). Their use is widespread in traditional medicine as antiseptic agents, laxatives 
31 
 
and diuretics. It has been well established that a diet high in fruits reduces the risk of cardiovascular 
diseases, cancer and other diseases mediated by oxidative stress (Carcache-Blanco et al., 2006).  
The phytochemical studies of the leaves showed that leaf extracts contain several phenolic 
compounds, like tannins, flavonoids, phenolic glycosides (Oliveira et al., 2009), as well as proteins 
like lectins (Ribeiro et al., 2012), among others. They are used as astringent, diuretic, urinary anti-
septic, antidiarrheal, depurative and more recently in the therapy of hypertension, diabetes and in 
the treatment of inflammatory diseases. Still, a recent study prove that leaf extracts exhibited 
excellent free radical scavenging activities and also potent in scavenging superoxide radical. This 
could be beneficial to prevent and treat illnesses and improve overall health of patients (Oliveira et 
al., 2009).   
 
4.2. Corema album L. 
The Corema album (Ericaceae) is an evergreen dioecious shrub which rarely exceeds 1 m in 
height. Corema album is endemic to the Atlantic coast of the Iberian Peninsula (Alvarez-Cansino 
et al., 2010). Its fruits are fleshy, more or less spherical berries (5-8 mm diameter) white or pink 
gently (Brunetti-Pierri et al., 2008; Mohamed et al., 2009). The edible berries are an important 
source of nutrients and phytochemicals, since they have been described as a good source of 
phenolic acids and flavonoids (Hariharan et al., 2008). 
The fruits of Corema album have high quantities of phenolic compounds which include 
phenolic acids, of flavonol glycosides, proanthocyanidins and anthocyanins. Its wealth in these 
bioactive principles gives them many properties beneficial to health, such as prevention of urinary 
tract infections, neuroprotection, decreased risk of cardiovascular disease and anticarcinogenic 
action (Kunnumakkara et al., 2012).  
The leaves are also rich in flavonoids and other secondary metabolites (Leon-Gonzalez et al., 
2014). A recent survey shows that extract from the leaves of Corema album L. have cytotoxic 
activity against the HT29 human colon adenocarcinoma cell line. Two dihydrochalcones, 2',4'-
dihydroxydihydrochalcone and 2'-methoxy-4'-hydroxydihydrochalcone, have been isolated from 
the leaves of C. album, both compounds showed higher cytotoxicity than the positive control 5-
fluorouracil (5-FU) (Leon-Gonzalez et al., 2013). Another study, also shows that Corema album 
leaves are rich in proteins like lectins (Nunes, 2014). 
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4.3. Juniperus L. 
The genus Juniperus L. belongs to the Cupressaceae family and condenses about 70 species, 
which are distributed in the Northern Hemisphere (Gutman and Kessler, 2006). These plants have 
an extensively history of use in global folk medicine for various disorders, such as common colds, 
urinary and kidney infections and dermatological disorders. Many biological activities have been 
reported for Juniperus sp. These include anti-inflammatory, diuretic, antiseptic (bacterial and 
fungal), anthelmintic, hypoglycaemic, hypotensive, abortifacient, anticonceptive, antiviral, 
anticancer, antioxidant, anticholinesterase and analgesic properties (Tavares et al., 2012).  
The Juniperus oxycedrus L., known as prickly juniper, plum or juniper juniper-red berries, is a 
shrub or small tree native throughout the Mediterranean region, Morocco and Portugal. J. 
oxycedrus L. includes three subspecies: subsp. oxycedrus, subsp. macrocarpa (Sm). Ball and 
subsp. badia (H. Gay) Debeaux. The fruit J. oxycedrus have cytotoxic activity to many types of 
human tumor cells and antioxidant activity (Helman et al., 2014). 
The Juniperus species represent a rich source in bioactive compounds, such as, catechins, 
procyanidins, flavonoid derivatives, flavones and biflavones, present in the leaves of the various 
species of Juniperus, that show to have cytotoxic effects against tumor cells of different origins 
(Tavares et al., 2013; Taviano et al., 2013).  
 
The bioactive principles present in Mediterranean flora have pharmacotherapeutic properties in 
various diseases, particularly in cancer. Their potential use in antitumor therapy has been 
investigated in recent years, and various in vitro and in vivo assays have been developed with 
positive effects. However, in the majority of the studies the bioactivities described have been 
attribute to various classes of active principles, with special relevance to the phenolic compounds 
and alkaloids.  
Until now the study of lectins has been relegated to a second plan. There are few studies relating 
the antitumor activity of these plants with the presence of lectins, and those that exist require 
additional testing to gain strength. So, for its antitumor mechanism of action and by the fact that 
the plants are an excellent reservoir of lectins, we consider to be promising its evaluation in species 
with pharmacologic properties already described. 
Recently, a study in protein extracts of four Mediterranean flora species, Juniperus oxycedrus 
var. oxycedrus, Juniperus oxycedrus var. badia, Arbutus unedo and Corema album, showed a 
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potential relevance for antitumoral activity. The lectins constituents of these extracts reveal 
recognition for glycosylated epitopes at the level of HT29 cells membranes from colorectal cancer. 
The binding of these lectins to HT29 cells and the exhibition of antitumor activity of these species 
allow us to study its responsibility on the antitumor activity as well in the mechanism involved in 
the cellular death. Therefore, after lectin recognition of the glycan specificity, they can be used as 
a probe for the recognition of the tumor cell or for therapy (Nunes, 2014). 
 
5. Aims  
The specificity of certain lectins for carbohydrates allowed their use in research, in order to 
recognize cells of different etiologies (red blood cells and tumor cells) using glycosylated receptors 
(glycolipids, glycoproteins and proteoglycans). An increasing number of studies have 
demonstrated that carbohydrates on the cell surface are modified during malignant transformation, 
yielding differences in cells that can promote cellular invasion, favoring the metastatic process (Xu 
et al., 2000). Studies with some lectins showed that they exhibit a greater binding on cancer cells 
compared to normal cells of the same type (Nunes, 2014).   
There is an increasing need for new therapeutic strategies for cancer in general, and also for 
colorectal cancer in particular, one of the most prevalent forms of cancer. Knowing that plants are 
excellent lectin reservoirs and that many lectins have already well described antitumor 
mechanisms, this project aims to select one of four species of Mediterranean endemic flora, 
including Juniperus oxycedrus var. oxycedrus, Juniperus oxycedrus var. badia, Arbutus unedo and 
Corema album, with hemagglutination activity already described. Using the selected species, we 
will purify and study the antitumor mechanism of one or more lectins, in human HT29 colorectal 
cancer cells, and will characterize the proteomic profile. 
This project is divided into four tasks: (1) screening of species with antitumor activity in HT29 
cells; (2) polypeptide characterization of selected species extract(s); (3) purification of lectins from 
selected species; and (4) final evaluation of antitumor mechanism of purified lectins in HT29 cells. 
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Chapter II – Materials and Methods 
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1. Screening of plant species with antitumor activity in HT29 cells 
1.1. Material  
1.1.1. Biological material 
Plant material 
To initiate the assays was used leaves from four plant species, particularly, Juniperus oxycedrus 
subsp. oxycedrus, Juniperus oxycedrus subsp. badia, Arbutus unedo and Corema album. 
Human material 
The HT29 cell line of colon carcinoma, from the species Homo sapiens, was a kind gift from 
Dr. Peter Jordan (Instituto Nacional de Saúde Doutor Ricardo Jorge), originally obtained from 
ATCC. 
 
1.2. Methods 
1.2.1. Human colon carcinoma cell line HT29 and cell culture  
All HT29 cell manipulations regarding culture maintenance, trypsinization, plating and extract 
incubations were carried out under sterile conditions in a laminar flow chamber. Cell culture 
maintenance was performed in cell incubators at 37 °C under a humidified atmosphere of 5% (v/v) 
CO2.  
The HT29 human cell line of colorectal carcinoma was grown in RPMI medium (Roswell Park 
Memorial Institute - Gibco, Life Technologies) medium supplemented with 10% (v/v) Fetal Bovine 
Serum (FBS) (Sigma), 2 mM Glutamine 0.5% (v/v), Penicillin (2 x 104 IU/mL) and 34 mM 
Streptomycin (Pen-Strep) and then was filtered in sterile microfilter (GVS Polyethersulfone 
Membrane 0.22 µm). The stock culture was maintained in flasks.  
When cells reached 80% of confluence, the medium was removed and trypsin (TrypLE Express 
- Gibco, Life Technologies) added for 15 min at 37 °C. The medium was then removed and 
centrifuged at 500 g, for 5 min, leaving only enough volume for cells to grow again. After 
centrifugation, the supernatant was removed and 1 mL of RPMI added to the pellet and 
homogenized. An aliquot was withdrawn from the cell homogenate and trypan blue was added to 
count cells in the Neubaumer's chamber. Cells were counted and the necessary volume calculated 
for the subsequent assays, followed by dilution with RMPI and plating. 
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1.2.2. Measurement of cell death and viability 
The evaluation of cell viability and cell death were performed using the MTS metabolism and 
lactate dehydrogenase assays, respectively. These assays were performed in parallel. 5 x 103 cells 
per well, in 96-well plate, were incubated with 100 µg/mL of each total proteins extracts of the 
species under investigation and with saline containing 2 mM CaCl2 and 2 mM MgCl2 as a control, 
for 48 and 72 h.  
 
1.2.2.1. Measurement of general cell death by lactate dehydrogenase (LDH) assay 
General cell death was evaluated using LDH Cytotoxicity Detection KitPLUS (Roche Diagnostics 
GmbH, Germany). The lactate dehydrogenase release assay measures membrane integrity as a 
function of the amount of cytoplasmic LDH released into the medium. The assay is based on the 
reduction of NAD by LDH. Reduced NADH is then used in the conversion of a tetrazolium dye to 
a colored product that is measured by a spectrophotometry at 490 nm.  
After incubation of 100 µg/mL of total protein extract in HT29 cells, 50 µL of culture 
supernatant was collected from each well and added to a new 96-well plate. Then the plate was 
incubated with 50 µL of assay substrate (prepared by mixing 1,11 µL of catalyst for each 50 µL of 
Dye Solution), for 10 to 30 min, at room temperature, protect from light. The absorbance was 
measured at 490 nm, with 620 nm reference wavelength using a Model 96 microplate reader 
(GLOMAX by Promega). 
 
1.2.2.2. Measurement of cell viability with MTS metabolism assay 
Cell viability was evaluated with CellTiter 96® Aqueous Non-Radioactive Cell Proliferation 
Assay (Promega), using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium, inner salt (MTS). In brief, this is a homogeneous, colorimetric 
method that detects viable cells in proliferation, cytotoxicity or chemosensitivity assays. The 
CellTiter 96®AQueous Assay is composed of solutions of MTS and an electron coupling reagent 
(phenazinemethosulfate, PMS). MTS is bioreduced by cells into a formazan product that is soluble 
in tissue culture medium. The conversion of MTS into the aqueous soluble formazan product is 
accomplished by dehydrogenase enzymes found in metabolically active cells, and is directly 
proportional to the number of viable cells in culture. 
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After removed the incubation media that will be used for LDH assay, the remaining incubation 
media was replaced by 120 µL MTS/PMS mix (100 µL of culture media, 19 µL of MTS and 1 µL 
of PMS). Then the cells were incubated at 37 ºC for 1 h. Changes in absorbance were measured at 
a wavelength of 490 nm, using a Model 96 microplate reader (GLOMAX by Promega). 
 
2. Polypeptide characterization of Arbutus unedo leaf extracts  
2.1. Material 
2.1.1. Biological material 
Plant material 
Was used leaves of Arbutus unedo. The final extracts were stored in -80 º C freezer in aliquots. 
Human material 
For this work was used membranes of cellular line HT29 of colon carcinoma.  
For the hemagglutination assays was used rabbit erythrocyte from Probiológica. 
 
2.2. Methods 
2.2.1. Arbutus unedo total protein leaves extraction 
The total protein extract of leaves from Arbutus unedo were obtained by an optimized method 
of extraction with buffer containing 5% (v/v) glycerol and 1% (v/v) Triton X-100, described by 
Silva and Souza (Silva and Souza, 2009). This method has a greater extraction power compared to 
other methods, since the solution contains Triton X-100, a non-ionic detergent which dissolves cell 
membranes and solubilizes proteins, while maintaining their native conformation. The original 
concentration of 4% (v/v) Triton was adjusted to 1% (v/v) to minimize cell lysis during assays 
performed in erythrocytes or HT29 cells. 
Leaves from A. unedo were powdered under liquid nitrogen, after which was added 0.25 g of 
polyvinylpolypyrrolidone per 0.5 g of fresh leaves, according to Silva and Souza. A protease 
inhibitor tablet containing 4-(2-aminoethyl) benzenesulfonyl fluoride (AEBSF), bestatin, pepstatin 
A, E-64, leupeptin and 1,10-phenanthroline (Sigma) was added at the beginning of the extraction 
procedure (1 tablet per 10 mL extraction buffer). The total proteins were extracted by adding 1 mL 
of extration buffer (Tris–HCl 0.5 M, pH 8.0, containing 5% (v/v) glycerol, 0.1 M KCl and 1% (v/v) 
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Triton X-100) per 0.5 g fresh leaves. The slurry was centrifuged at 14,000 g for 30 min at 4 ºC, the 
supernatant was filtered with Miracloth (Calbiochem) and desalted through PD-10 columns 
previously equilibrated in Tris–HCl 0.05 M, pH 7.5 buffer, containing 2 mM CaCl2 and 2 mM 
MgCl2. 
 
2.2.2. Determination protein concentration by Bradford Method 
A subsequent determination of total proteins by Bradford Method (Bradford, 1976) was 
performed. These method is a colorimetric assay that involves the interaction of the dye Coomassie 
Brilliant Blue G250, dissolved in phosphoric acid and methanol (Bradford Reagent), with the basic 
or aromatic amino acid side chains, promoting a blue coloration by the stabilization of the dye 
anionic form, being more intense the greater the amount of protein present in the sample. This 
colour change can be quantified by measuring the absorbance at a wavelength of 595 nm, helping 
to determine the protein concentration. This assay is fast and highly reproducible. 
Protein concentration was establish using a calibration curve in 96-well plates. For the 
calibration curve was used Bovine Serum Albumin (BSA) as standard protein with concentrations 
between 0 and 25 µg and in triplicates. The samples of total extract protein were also applied in 
triplicates. Finally, the Bradford reagent (BioRad) was added in all wells and incubated for 15 min, 
at room temperature, protect from light. Absorbance readings were measured at 595 nm (Software 
KinetiCalc – KC 4). 
 
2.2.3. Polypeptide profile evaluation by electrophoresis 
In order to evaluate the polypeptide profile of total protein extract, electrophoretic separations 
were carried out on polyacrylamide gels under denaturing and reducing conditions (SDS-PAGE 
R), according to the methodology described in Santos (Santos et al., 1997). 
This technique is based on the amphoteric property of proteins and separation by molecular 
weight. The proteins are subjected to an electric field, where its mobility, from the cathode to the 
anode, depends in the first instance of it’s load and it’s size, and therefore, a migration according 
to their molecular weight, implies that all proteins have a similar charge density/mass. This is 
achieved by the addition of denaturing agents to the sample as SDS (anionic detergent), which will 
impart an overall negative charge to the polypeptides. The SDS has the ability to form a strong 
complex SDS/polypeptides due to their apolar character, connecting to micellar form to protein 
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apolar regions, and being its ionic area exposed to the solvent (Robyt and White, 1990). The 
binding of SDS to protein promotes two distinct effects, the dissociation of protein oligomers and 
the disruption of the protein secondary structure. Also, saturation of the protein with SDS leads to 
camouflage protein load, and the migration in the gel became to be completely dependent on their 
molecular weight (Plummer, 1987). The use of β-mercaptoethanol promotes the reduction of 
possible disulphide bonds (Robyt and White, 1990). 
The separation gel consisted of an acrylamide matrix of 17.5% (w/v), 0.1% (w/v) bisacrylamide, 
375 mM Tris-HCl buffer pH 8.8, 0.03% ammonium persulfate (PSA), 0.03% (v/v) 
Tetramethylethylenediamine (TEMED). The concentration gel consist of 5% (w/v) acrylamide 
matrix, 0.13% (w/v) bisacrylamide, 125 mM Tris-HCl buffer pH 6.8, 0.1% (w/v) ammonium 
persulfate (PSA), 0.05% (v/v) Tetramethylethylenediamine (TEMED). A 16 cm x 18 cm x 0.75 
mm gels are normally used. After assembly of the vertical system and its sealing was verified, the 
constituent solutions of the gel were added with a micropipette. The separation gel was initially 
applied up to 2 cm from the top of the glass, which was covered with a thin layer of butanol, 
avoiding the formation of undesirable surface air bubbles in order to favor uniform polymerization. 
After polymerization, all the butanol was removed from the vertical system, then was added the 
concentration gel, after insertion of the comb into the mold, to form the filling wells. The gel, after 
polymerization, were placed in the electrophoresis chamber (HOEFER SE 600 Ruby from 
Amersham Biosciences) and was added the electrophoresis buffer solution (200 mM Glycine, 25 
mM Tris-Base, 0.02% (w/v) SDS) in order to cover the electrodes. The electrophoresis was 
performed under reducing conditions using sample buffer contained 100 mM β-mercaptoethanol. 
All sample were denatured at 100ºC for, 4 min, followed by application on the gel, where it was 
also applied 3 μL of molecular weight marker (BioRad), ranging from 10 to 259 kDa. The gel was 
subjected during running to an electric current of 70 milliamperes (mA) and a potential difference 
of 220 V (Pharmacia Gene Power Supply EPS 600) per unit of gel. The run finished when the 
bromophenol blue (front-line marker) reached the end of the gel.  
 
2.2.4. Polyacrylamide gel staining by silver nitrate 
For the staining of the polyacrylamide gel by silver nitrate (AgNO3), the method of Blum was 
applied (Blum et al., 1987). These method is based on the ability of proteins have to bind to silver 
ions (Ag+). It is believed that complexation of Ag+ ions with amino groups, occurs in an alkaline 
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environment and in the presence of sulphur from the methionine and cysteine residues. The matrix 
of the separated proteins gel is saturated with Ag+ ions. These ions preferentially bind to basic 
amino acids with characteristics of surface proteins from the gel matrix and, ions that do not bind 
to any amino acid have to be removed.  
The staining procedure was initiated by immersing the gel in a fixing solution (50% (v/v) 
methanol, 12% (v/v) acetic acid and 0.02% (v/v) formaldehyde) and placed on an orbital shaker 
with low stirring for 20 min, there being no inconvenience of overnight development. The fixing 
solution was discarded and the gel was washed three times, for 10 min each, with wash solution in 
50% (v/v) ethanol. After removal of the washed solution, a pre-treatment was carried out for 1 min 
by immersing the gel in a 0.02% (v/v) sodium hyposulfite solution, after which the gel was washed 
with distilled water, for 20 s each, three times. The staining solution (11 mM AgNO3, 0.03% (v/v) 
formaldehyde) was added, allowing contact with the gel for 10 min, then washing twice with 
distilled water for 20 seconds each. After a development solution (566 mM Na2CO3, 0.02% (v/v) 
formaldehyde, 16 μM Na2S2O3) was added during the time required for the appearance of the 
bands. At the end the staining reaction was stopped by immersion the gel in stop solution (50% 
(v/v) methanol, 12% (v/v) acetic acid). The gels were conserved after dehydration in cellophane 
sheet. 
 
2.2.5. Lectins detection 
After protein extraction, we confirmed the presence of lectins with hemagglutination assay using 
rabbit erythrocytes. Also, we verified the specificity of these lectins against a panel of selected 
sugars.  
The blood group is defined by antigens (glycoproteins and glycolipids) present in the 
erythrocyte cell membrane. These genetic markers are species-specific and differ in 
immunogenicity. A set of two or more alleles at a locus constitutes the blood system. The general 
term used to describe the visible agglomeration of erythrocytes is hemagglutination. Lectins 
possess the ability to induce cell clumping phenomenon and the presence of this family often 
detected using hemagglutination assay (Ribeiro et al., 2012). Many lectins recognize differences 
between blood group antigens.  
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2.2.5.1. Preparation of rabbit trypsinized erythrocyte solution at 4% (v/v) 
The total protein extract obtained as described in 2.2.1. was tested against a rabbit erythrocyte 
solution at 4% (v/v).  
After receiving the blood collected by the Probiológica, a previous centrifugation, 1,100 g was 
carried out, for 6 min, in order to separate the pellets (sediment) from the respective plasma. 
Washing of the globules was followed by saline (40 mL of saline:5 mL of blood) three times. For 
each wash was performed a centrifugation (1,100 g, for 6 min, 13 ºC) in order to separate the 
globules, discarding the supernatant. The washed and sediment erythrocytes (the pellet occupies a 
volume of approximately 4 mL) were resuspended in 96 mL of saline to which trypsin (Sigma) at 
the final concentration of 1% (w/v) was added and incubated 1 h at 37 ºC with stirring. Further 
centrifugation (1,100 g, for 6 min, 13 ºC) was performed to remove the supernatant, and three new 
washes were carried out as before. Finally, the sedimented erythrocytes were resuspended in 96 
mL of saline solution and left with a solution of 4% (v/v) erythrocytes. 
These erythrocytes thus treated were divided and stored at 4 ºC for use in hemagglutination 
tests. The erythrocyte solution was considered within the validity while it did not show erythrocyte 
hemolysis. 
 
2.2.5.2. Hemagglutination assay 
The hemagglutination activity was determined by serial dilution method on microplates 
(microdilution). In this assay, a serial dilution of the total protein extracts is performed in saline 
(NaCl 0.9% (w/v)), in a geometric progression of ratio 3, followed by incubation with rabbit 
trypsinized erythrocytes at 4% (v/v). The hemagglutination activity is expressed as 
Hemagglutinating Units (H.U.), considering as the lowest concentration of protein that still 
expresses hemagglutination activity on the erythrocyte. This activity is determined by the ratio 
between the concentration of total protein and tested 3n-1, with n being equal to the last dilution 
which still exhibits hemagglutination activity (Ribeiro et al., 2012). 
 
𝐻. 𝑈. =
total protein
3𝑛−1
 
Assay performed on 96-well plate with U-bottom. A volume of 70 µL of saline was deposited 
in each well of the plate. The protein sample was deposited in the volume of 70 µL, containing 50-
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100 µg of protein in saline solution (containing 2 mM CaCl2 and 2 mM MgCl2), in the first well 
and a serially dilution 1:3 of the sample was started. After that, 70 µL of the erythrocyte solution, 
4% (v/v), was deposited in all wells and the protein was diluted 1:3. A negative control (-) of saline 
and a positive control (+) of concanavalin A (1 mg/mL) were always present. The plate was 
incubated without stirring at 37 °C, for 30 min. 
A negative result is revealed by the formation of a red blood cell precipitating nucleus 
surrounded by a clear colourless supernatant. A positive result is manifested by the adherence of 
the erythrocytes to the bottom of the plate, forming a coating and sometimes may also exhibit a 
certain retraction of the erythrocyte coating. 
 
2.2.5.3. Determination of hemagglutination activity inhibition by carbohydrates 
The definition of the glycoside specificity of a lectin can be achieved by assays of inhibition of 
hemagglutination activity with different monosaccharides and polysaccharides (Sharon and Lis, 
1990). 
The specificity tests of carbohydrates, were carried out as described by Ribeiro and colleagues 
(2012). Four hemagglutination units (H.U.) of the protein in study were incubated with a battery 
of 16 carbohydrates, each diluted at the ratio of 1 to 3. Carbohydrates used in the test were: glucose 
(0.1 M); glucosamine (0.1 M); N-acetyl-D-glucosamine (0.1 M); galactose (0.1 M); galactosamine 
(0.1 M); N-acetyl-D-galactosamine (0.1 M); lactose (0.1 M); mannose (0.1 M); raffinose (0.1 M); 
D-fucose (0.3 M); melezitose (0.1 M); methyl-α-glucopyranoside (0.1 M); methyl-α-mannoside 
(0.1 M); sucrose (0.1 M); N-acetylneuraminic acid (0.1 M) and L-fucose (0.3 M). 
This assay was performed in microplate with the U-bottom, where a volume of 70 µL of saline 
was added in each well of the plate. Each sugar (70 µL) was successively diluted 1:2 in saline. 
After that, the protein sample (4 U.H.), in a 70 µL volume was deposited in each well. It was 
allowed to incubate for 1 h, at room temperature. Finally, 70 µL of erythrocyte solution at 4% (v/v) 
was deposited in all wells, being the diluted sugar 1:3. It was allowed to incubate again for 1 h, at 
room temperature. Negative and positive controls were always performed, as described in 2.2.5.. 
A positive result is revealed by the formation of a red blood cell precipitating nucleus 
surrounded by a clear colourless supernatant. In these cases, there were inhibition of 
hemagglutination, meaning that the sugar, bound to the protein revealing specificity and the protein 
was unable to bind to the glycosylated receptors of erythrocytes, minimal inhibited concentration 
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(m.i.c.). In these cases, the minimum sugar concentration that still causes inhibition of agglutination 
is noted. A negative result is manifested by the adherence of the erythrocytes to the bottom of the 
plaque, forming a coating meaning that the protein did not bind to sugar. 
 
2.2.6. Polypeptide binding to HT29 cell membranes 
The total protein extract from Arbutus unedo leaves, was incubated with HT29 membranes for 
assess the binding potential of proteins to glycosylated cell membranes receptors.  
Membranes isolation 
The HT29 cell stored in cryotubes at -80 °C, were thawed rapidly at 37 °C, and the cell 
suspension was pooled into a conical tube, to which was added 10 volumes of HES buffer (20 mM 
HEPES, pH 7.4, 250 mM sucrose), for washing and elimination of the cryocrystallization medium, 
by centrifugation at 750 g, for 10 min, at 21 °C (Beckman J2 -21M/E, Rotor JA 20.000). The 
supernatant was discarded and the wash operation was repeated for one more time, the pellet 
obtained was resuspended in HES buffer, added protease inhibitor cocktail (EDTA-free, Roche). 
The cell lysis was performed by cryolysis, where the cells were subjected to a freeze-thaw (4x), for 
30 min at -20 °C, associated with sonic sonication for 20 min. A centrifugation at 960 g was carried 
out for 10 min, at 4 ° C, and the pellet was discarded at the end. Finally, the supernatant was 
ultracentrifuged at 10,000 g, for 45 min at 4 °C (Beckman J2 -21M/E, Rotor JA 20.000). The pellet, 
containing the cell membranes, was resuspended in 2 mL of saline solution (0.9% (w/v) NaCl) 
containing 2 mM CaCl2 and 2 mM MgCl2. Subsequently, the pellet was divided into aliquots 
containing 1 mg of protein, after determination of the protein content by the Bradford method, 
according to the procedure described in 2.2.2..  
 
Protein extract HT29 cells membranes incubation 
A 1000 µg of HT29 membranes previously solubilized in 3.5 mL of saline containing 2 mM 
CaCl2 and 2 mM MgCl2, were incubated with 1.4 mg of total protein extract also in saline 
containing 2 mM CaCl2 and 2 mM MgCl2, during 35 min, at 25 ºC, with gentle shaking. After this 
time, was realized a sequence of three centrifugations, at 12,100 g and 4 ºC, during 8 min, in order 
to remove the proteins that does not bind to membrane. In the end of each centrifugation the 
supernatant was discard and 10 volumes of saline containing 2 mM CaCl2 and 2 mM MgCl2 were 
added to pellet. After the last centrifugation, the pellet was solubilized in saline containing 2 mM 
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CaCl2 and 2 mM MgCl2. In parallel, a blank assay was performed, replacing the total protein extract 
by saline containing 2 mM CaCl2 and 2 mM MgCl2. 
 
2.2.6.1. Polypeptide binding protein to HT29 membranes by SDS-PAGE R evaluation 
To evaluated the binding of total protein extract to HT29 membranes was performed an 
electrophoretic technique by SDS-PAGE R as previous described in 2.2.3.. It was applied 13 µg of 
HT29 membranes, 50 µg of total protein extract and 13 µg of HT29 membranes incubated with 
total protein extract. To visualized the gel was performed a silver nitrate staining, as previous 
described in 2.2.4.. 
 
3. Purification of Arbutus unedo lectins  
3.1.  Arbutus unedo lectins purification by Q-Sepharose  
The first step for lectins purification from the total protein extract of A. unedo leaves, was with 
an anion exchange column of Q-Sepharose gel (quaternary ammonium salt from Pharmacia). 
A 20 mL of total protein extract (obtained as described in 2.2.1.) in buffer A (Tris-HCl 50 mM, 
pH 7.5, 2 mM CaCl2 and 2 mM MgCl2), was injected in a Q-Sepharose column, previously 
equilibrated in buffer A. During the chromatography procedure, in AKTA apparatus (FPLC - fast 
protein liquid chromatography), the unadsorbed proteins on the column were pooled and stored at 
-80 º C, for subsequent assays. Elution of the adsorbed proteins from the column was done by 
stepwise gradient: 0-20% step gradient in 4 column volumes (CV), 20-30% in step gradient 4 CV, 
30-40% 3 CV, with later linear gradient of 40-60% 2 CV and finally step gradient 60-100% in 3 
CV of buffer B (Tris-HCl 50 mM, pH 7.5, 1 M NaCl, 2 mM CaCl2 and 2 mM MgCl2), taking into 
account that a column volume was 6 mL. The gradient was formed automatically by mixing buffer 
A with buffer B. 
The chromatographic fractionation was carried at a flow rate 1 mL/min of buffer solution and 
with continuous reading of absorbance at 280 nm. The eluates were collected by monitoring of the 
chromatogram. After elution, the protein quantification by the Lowry method was performed. 
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3.1.1. Determination protein concentration by Lowry method 
 The Lowry method (Lowry et al., 1951) is one of the most sensitive procedures for protein 
quantification, however it is influenced by numerous interfering substances. Bensadoun and 
Weinstein (Bensadoun and Weinstein, 1976) developed a technique based on the traditional 
method, which allows to overcome some of these interfering factors. 
The Lowry method is based on the ability of the protein to react with copper in an alkaline 
medium (biuret reaction), forming a complex capable of reducing the Foli-Ciocalteau reagent 
(phosphomolybdenum and phosphotungsten), resulting in a compound of intense blue color that 
absorbs at 750 nm. By a previous precipitation with trichloroacetic acid (TCA), associated to the 
solubilizing effect of the sodium deoxycholate, a protein precipitate is obtained, which ensures 
reproducibility in the quantification of proteins, eliminating the interfering materials. 
A calibration curve was constructed with BSA solutions of concentrations between 0 and 35 µg. 
To the BSA solutions, as well as to the sample solutions, water was added to make up 250 µL. 
After 50 µL of 1% (w/v) sodium deoxycholate and 1 mL of 10% (w/v) TCA was added. After 10 
min incubation, the samples were centrifuged for 5 min at 10,000 g, the supernatant was discarded. 
The previously formed protein precipitate was resuspended in 1 ml of reagent C (reagent B (4% 
(w/v) of copper sulphate pentahydrate) diluted 1:100 in reagent A [2% (w/v) of sodium carbonate, 
0.4% (w/v) sodium hydroxide, 0.16% (w/v) sodium tartrate and 1% (w/v) SDS]. After 10 min, 100 
µL of Folin-Ciocalteau reagent diluted in water (1:1) were incubated in the samples, in the dark, 
for at least 30 min to a maximum of 3 h, after which the absorbance was read at 750 nm in a 
spectrophotometer Shimadzu UV-2100. 
 
3.1.2. Lectins detection 
After protein concentration determination, hemagglutination assays were carried out to check 
for the presence of lectins in all samples, including the unadsorbed fraction, according to the assay 
described in 2.2.5.2.. After that, sugar specificity was determined only for the sample which 
showed hemagglutination activity, the unadsorbed fraction, called from now on “unadsorbed Q-
Sepharose” (Unds Q-Seph), using the method described in 2.2.5.3.. 
At the same time, the polypeptide profile of the same samples was evaluated through a 
polyacrylamide gel electrophoresis. The procedure was the same as described in 2.2.3., and the 
amount of protein samples applied on the gel was: 40 µg for the total protein extract, 20 µg for the 
48 
 
unadsorbed sample to Q-Sepharose and 7 µg for all eluates. To visualized the gel was performed a 
silver nitrate staining, as previous described in 2.2.4.. 
 
3.2. Unadsorbed Q-Sepharose lectins purification by affinity columns 
Proteins that did not bind to the Q-Sepharose (unadsorbed Q-Sepharose fraction) and exhibit 
hemagglutination activity, were pooled and applied on three different affinity columns. These 
columns were chosen based on the sugar affinity assays.  
Affinity chromatography is a technique used to purify compounds, such as proteins, that have 
the ability to non-covalently and reversibly bind specific molecules, known as ligands. Before 
loading the sample, the gel was equilibrated with an adequate buffer (binding buffer), after what 
the sample was loaded, in the same buffer. After washing the column with the same buffer, the 
lectins bound to the matrix were eluted by the elution buffer containing a specific sugar for each 
lectin (determined by the previous inhibition of hemagglutination activity assays). The eluates were 
monitoring at 280 nm for detected the eluted protein. The eluted lectin, after protein quantification, 
was visualized by electrophoretic profile and characterized concerning the lectin profile by 
hemagglutination activity (Pohleven et al., 2012). 
 
3.2.1.  Protein separation by affinity columns 
The three columns used were selected based on the previous sugars inhibition tests performed 
on total protein extract and unadsorbed Q-Sepharose fraction. Thus, the first column in which the 
unadsorbed Q-Sepharose sample was tested was N-acetyl-D-glucosamine (Vector), followed by D-
galactose (Pierce) and finally, N-acetyl-D-galactosamine (Sigma). 
Each column was prepared with 500 µL of the respective affinity gel. The column protocol was 
started by washing with 10 volumes of distilled water three times to remove all the preservation 
solution. The equilibrium washing of the column was followed by 10 volumes, twice, with the 
respective binding buffer, for N-acetyl-D-glucosamine and N-acetyl-D-galactosamine columns was 
used 10 mM TBS, pH 7.5, and for D-galactose (Pierce) column was 0.1 M TBS, pH 7.2. Once the 
column was equilibrated, the Q-Seph Unds fraction (previously equilibrated in the column buffer) 
was loaded. After entering the sample, 10 volumes of the equilibration buffer were applied to 
remove proteins which did not bind or which were non-specifically bound to the column. Elution 
of the proteins bound sugar matrix of each column was followed with elution buffer, which is equal 
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to the elution buffer with addition of the respective sugar for each column, for N-acetyl-D-
glucosamine column the sugar was 0.4 M of N-acetyl-D-glucosamine, for D-galactose column the 
sugar was 0.2 M D-galactose and for the N-acetyl-D-galactosamine column the sugar was 0.3 M N-
acetyl-D-galactosamine. Elution was carried out by eluates absorbance measure at 280 nm.  
After all eluates were collected, NAP 10 columns containing the Sephadex G-25 gel, were used 
for sugar removal and exchange of the buffer with saline containing 2 mM CaCl2 and 2 mM MgCl2 
and by ultrafiltration systems. After the affinity column, hemagglutination activity was determined, 
as described in 2.2.5.2., in unadsorbed fraction and on eluates. Subsequently, an SDS-PAGE-R gel 
was performed in order to evaluate the polypeptide profile of the samples with hemagglutination 
activity. 
 
3.3. Unadsorbed Q-Sepharose lectins purification by Mono S 
Before proceeding with Mono S column, it was checked whether the lectins present in the 
unadsorbed Q-Sepharose sample did not lose hemagglutination activity at low pHs. For this, the 
hemagglutination activity was tested after subjecting the sample to low pH.  
The sample was incubated in citrate buffer 20 mM, at pH 2.0, 2.5, 3.0, 3.5 and 4.0, for 30 min, 
at 4 ºC. The NAP-10/PD-10 columns were used to exchange the buffer. After this time, the samples 
were centrifuged at 10,000 g, for 10 min, in order to remove the proteins which had undergone acid 
hydrolysis. The supernatant was collected and the samples were passed to 50 mM Tris-HCl, pH 
7.5 buffer through NAP-10/PD-10 columns. At the end, the samples were transferred to saline 
solution and hemagglutination assays were performed, as described in 2.2.5.2.. 
 
After determining that the sample did not lose the hemagglutination activity at low pHs, we 
continued with lectins purification, present in the unadsorbed Q-Sepharose sample, using the Mono 
S column, a strong cation exchanger (Resource S). 
A  8 mL of total unadsorbed Q-Sepharose fraction in buffer A (20 mM phosphoric acid and 
NaOH, pH 2.0, 2 mM CaCl2 and 2 mM MgCl2) was injected Mono S column, previously 
equilibrated in buffer A. During the chromatography procedure, in AKTA apparatus, the 
unadsorbed proteins on the column were rapidly neutralized using the PD-10 equilibrated with 50 
mM Tris HCl buffer, pH 7.5 and stored at -80 º C for subsequent assays. Elution of the adsorbed 
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proteins to the column was done in a 0-100% linear gradient of buffer B (20mM phosphoric acid 
and NaOH, pH 2.0, 1 M NaCl, 2 mM CaCl2 and 2 mM MgCl2). Gradient formed automatically by 
mixing buffer A with buffer B. The chromatographic fractionation was carried at a flow rate 1 
mL/min of buffer solution and with continuous reading of absorbance at 280 nm. The eluates were 
collected by visualization of the chromatogram, and the same procedure used in the unbound 
protein was used here. 
For all Mono S column chromatography samples collected were performed hemagglutination 
assays, as described in 2.2.5.2., in order to detect the presence of lectins. After hemagglutination 
results analysis, an SDS-PAGE-R gel was performed in order to evaluate the polypeptide profile 
of the sample that showed hemagglutination activity, which was unadsorbed to the Mono S column 
fraction. 
 
3.4. Proteomic analysis (2D) of purified lectins binding to HT29 cells 
membranes 
The proteomic analysis of the purified lectins from Mono S column, that after incubation bind 
to the glycosylated receptors of the HT29 membranes was performed. For evaluate the polypeptide 
binding, electrophoretic techniques, namely, two-dimensional electrophoresis (2D) was performed. 
This technique increases the resolution in the separation of proteins in order to permit the 
identification of its various isoforms, with molecular weight and isoelectric point characterization. 
Two-dimensional electrophoresis technique is a compromise of two protein separation 
techniques, isoelectric focusing (IEF) and a unidimensional electrophoresis (SDS-PAGE-R). The 
first dimension is the IEF that is based on the amphoteric property and the isoelectric point (pI) of 
the protein. Proteins are placed on a polyacrylamide gel with a pH gradient (strip) and subjected to 
an electric field, which migrate until reaching the pH corresponding to their pI. The second 
dimension is an SDS-PAGE-R, and does not include a concentration gel prior to the separation gel, 
since proteins are already concentrated in the IEF strip.  
The preparation of the sample is essential to free it of salts, detergents, phenols, nucleic acids 
and polysaccharides, compounds which interfere with the migration of the polypeptides into the 
gel. For this assay, we test the sample obtained after incubation of the unadsorbed Mono S fraction 
with HT29 membranes (1 mg of HT29 membranes and 500 µg of unadsorbed Mono S fraction), 
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and we also used 1 mg of HT29 membranes and 500 µg of unadsorbed Mono S fraction, as control, 
for membranes and sample, respectively. 
All the samples were pre-treated by exchanging extraction buffer for MilliQ water using PD-10 
columns (GEHealthcare), and washing (3 to 4 times) by ultrafiltration in centricons (Microsep 
Advanced Centrifugal Devices, PALL) of cut-off 10 kDa using MilliQ double-distilled water. After 
three washes the samples were precipitated with acetone and the pellet resuspended in the required 
volume of IEF solubilisation buffer (7 M urea, 2 M thiourea, 2% (v/v) NP-40, 1% (w/v) DTT), 
added IPG buffer 4 μL of IPG added to 200 μL of solubilisation buffer, for IEF strips, 11 cm). 
After solubilisation, the samples were centrifuged at 21,500 g, for 10 min (VWR CT15RE). 
Focusing strips impregnated with immobilins, IPG (immobilized pH gel) strips of 11 cm, forming 
a pH gradient of 3 to 10, obtained commercially from BioRad, were used. 
The protein samples were deposited in the aisles of the IPGphor support (sarcophagus), and the 
IEF strips were placed on the samples. The gel side was always in contact with the samples and the 
strips were placed according to the respective poles of the focusing device holder (IPGphor). 
Thereafter, the carrier (sarcophagus) was placed in the focusing apparatus and rehydration was 
scheduled overnight for 12 hours, 30 V.h. After the rehydration, the run was performed in six steps 
programmed as follows: step 1 - 250 V.h, 1 h; Step 2 - 500 V.h., 2 h; Step 3 - 1000 V.h, 2 h; Step 
4 - 2500 V.h, 3.5h; Step 5 -8.000 V.h, 1h; Step 6 - 8,000 V.h, 25 min. After the isoelectric focusing 
was completed, the strip was removed and conditioned in a glass tube and stored at -80 º C until 
tested for 2D analysis. 
After isoelectric focusing (1D-IEF), the strip was incubated in stabilization buffer 50 mM Tris-
HCl, pH 8.8, 6 M urea, 2% (w/v) SDS, 30% (v/v) glycerol, 1% (w/v) dithiothreitol (DTT), 15 min 
at room temperature with gentle shaking. After the first incubation, the strip was re-incubated for 
DTT removal, for 15 min under mild agitation with a similar solution as above containing 2.5% 
(w/v) iodoacetamide (replacing dithiothreitol). After the last incubation, the strip was placed on the 
top of a 17.5% (w/v) acrylamide SDS-PAGE gel, 1 mm thick, sealed with a low electroendosmosis 
(EEO) agarose solution at 0.5% (w/v), performed in 50 mM Tris-HCl buffer, pH 8.8, containing 
0.002% (w/v) bromophenol blue, for frontline visualization during electrophoretic separation. The 
electrophoretic conditions, initially of 15 mA and 220 V, were established for 15 min for sample 
entry into the gel, followed by an electric current of 30 mA and a potential difference of 220 V, 
until the end of the run. After running the gel, it was staining by silver nitrate, as described in 2.2.4..  
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4. Antitumor activity final evaluation of purified lectins in HT29 cells 
4.1. Material 
4.1.1. Biological material 
Plant material 
For this last task, it was used Arbutus unedo total protein extract and the fraction of mono S 
column with hemagglutination activity (unadsorbed Mono S, call from now lectin). These samples 
were stored in -80 º C freezer in aliquots.  
Human material 
The same cell line HT29 was used for the screening of the species with antitumor activity. 
 
4.2. Methods 
After lectin purification, the antitumor activity was tested. Cell viability and cell death was 
measure in HT29 cells exposed to 25, 50, 100 and 250 µg/mL of total extract and purified lectin, 
for 72 h. Cell viability and cell death were evaluated by MTS metabolism and LDH release assays, 
respectively, as previously described in 1.2.2. of Chapter II. 
 
4.2.1. Morphological evaluation of apoptosis in cultured cells 
Apoptotic cells can be identified based on their typical nuclear morphological changes, such as 
chromatin condensation and nuclear fragmentation. Therefore, nuclear morphology was assessed 
using the DNA-binding stain Hoechst. This assay provides a rapid and convenient way of assessing 
apoptosis based on fluorescence detection of nuclear morphological changes characteristic of 
apoptosis. The blue-fluorescent Hoescht dye 33258 stains chromatin, and normal nuclei are 
identified as non-condensed chromatin dispersed over the entire nucleus, whereas apoptotic nuclei 
are characterized by condensed chromatin, contiguous to the nuclear membrane, as well as by 
nuclear fragmentation of condensed chromatin. 
For this purpose, HT29 cells were seeded into 35 mm dishes, at density of 50 x 103 cells per 
dish, and exposed to total protein extract and purified lectin. Attached cells were fixed with 4% 
(v/v) paraformaldehyde in phosphate-buffer saline (PBS) for 20 min at room temperature, protected 
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from light. Subsequently, cells were washed with PBS and mounted with coverslips using 
PBS/glycerol (3:1). Nuclear morphology was evaluated by fluorescence microscopy using an 
AxioScope.A1 microscope (Carl Zeiss Microscopy GmbH, Jena, Germany). Images were acquired, 
under 400x magnification, using an AxionCam HRm camera with the AxionVision software 
(release 4.8; both from Carl Zeiss Microscopy GmbH). A minimum of five random microscopic 
fields with approximately 100 nuclei were counted for each condition, from at least three 
independent experiments. Fluorescent nuclei were categorized according to the condensation and 
staining characteristics of chromatin. 
 
4.2.2. Evaluation of caspase-3/7 activity 
Caspases are a family of cysteine proteases that play a critical role in programmed cell death, 
and caspase activation represents one of the earliest measurable events of apoptosis. Accordingly, 
the detection of effector caspase-3 and -7 activation status is frequently used as a general marker 
of apoptosis. Caspase-3 and -7 activity was measured using the Caspase-Glo 3/7 Assay (Promega). 
This assay is based on the cleavage of a proluminescent substrate containing the specific DEVD 
sequence recognized by caspase-3 and -7 to release aminoluciferin. Generates a luminescent signal 
directly proportional to the amount of caspases activity present in the sample. 
HT29 cells were seeded on a 96-well plate at a 5 x 103 cells per well. Total protein extract and 
purified lectin were incubated, 75 µL of Caspase-Glo 3/7 reagent was added to each well, and 
plates were mixed by orbital shaking for 30 s. Subsequently, the mixture was incubated at room 
temperature for 30 min, leading to complete cell lysis, stabilization of substrate cleavage by 
caspases, and accumulation of luminescent signal detected by the GloMax-Multi+ detection system 
(Promega). 
 
Statistical analysis 
All data were expressed as mean ± Standard Error of Mean (SEM) from at least three 
independent experiments. Statistical significance was evaluated using the Student’s t test. Values 
of p < 0.05 were considered significant. 
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Chapter III – Results and Discussion 
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1. Screening of plant species with antitumor activity in HT29 cells 
The total protein extract from Juniperus oxycedrus subsp. oxycedrus, Juniperus oxycedrus 
subsp. badia, Arbutus unedo and Corema album were selected based on previous studies that show 
that all their extracts contain protein-like lectins based on hemagglutination activity. In addition to 
the hemagglutination activity assay, the wound assay and the inhibition of metalloproteinases 
MMP2 and MMP9 activities have been tested for these four extracts, also in HT29 cells (Nunes, 
2014).  
The results showed that Juniperus oxycedrus subsp. badia was the the most effective at 
inhibiting cellular invasion, with 33% of invasion of the cut, promoting a cut-off inhibition of 
approximately 50% compared to the control. This extract also showed a promising inhibition of 
gelatinase activity as compared to the control, with a reduction of approximately 25% in MMP2 
and MMP9 activity being observed. Arbutus unedo also showed good results in these two assays, 
with 26% of invasion of the cut, and with 25% of MMP2 and MMP9 inhibition. For the species 
Juniperus oxycedrus subsp. oxycedrus and Corema album, only the wound test was performed, 
showing a cut off percentage of 68% and 41%, respectively, but evidencing a lower percentage 
inhibition of cell invasion compared to the control (Nunes, 2014). 
 
 
To continue with the previous work, we investigated cell death in HT29 cells, using the four 
total protein extracts, Juniperus oxycedrus subsp. oxycedrus (Joox), Juniperus oxycedrus subsp. 
badia (Joba), Arbutus unedo (Aun) and Corema album (Cal), to then select the most promising 
species.  
 
 
Figure III-1 shows that all tested species have the capacity to induce cell death and decrease 
cell viability. However, there are differences among species. The Juniperus oxycedrus subsp. 
oxycedrus protein extract induced a large increase in LDH activity after 48 h, which decreased after 
72 h. The MTS metabolism was decreased by about 20 to 25% in relation to control. The Juniperus 
oxycedrus subsp. badia protein extract reveals the slightest effect, not checking big difference 
between the two endpoints in both assays. On the other hand, Arbutus unedo and Corema album 
showed very similar results being the samples with increased LDH activity, and this increase was 
58 
 
greater after 72 h. The MTS metabolism assay for these two species showed a good reduction of 
the MTS metabolism; however, Corema album was the species, among the four, with the greatest 
reduction of MTS metabolism after 72 h. 
 
Since Arbutus unedo and Corema album total protein extracts here the two species with better 
results, and in order to select one species, we looked for the previous results obtained in our sample. 
Therefore, knowing that Corema album was less effective in the tumor invasion assay, we selected 
the Arbutus unedo to proceed with lectins purification. 
 
 
 
 
Figure III.1 – Cytotoxicity assays in HT29 cells exposed to 100 µg/mL of total protein extract from 
Juniperus oxycedrus subsp. oxycedrus (Joox), Juniperus oxycedrus subsp. badia (Joba), 
Arbutus unedo (Aun) and Corema album (Cal), for 48 and 72 h. Saline containing 2 mM CaCl2 and 
2 mM MgCl2 was used as control. General cell death (A) and cell viability (B) were evaluated by LDH 
realease and MTS metabolism assays, respectively. Results are expressed as mean ± SEM fold-change to 
control from three independent experiments *p <0,01 and †<0,05 for HT29 cells. 
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2. Polypeptide characterization of Arbutus unedo leaf extracts 
2.1. Arbutus unedo total protein extract analysis vs. polypeptide binding to 
HT29 cells 
2.1.1. Hemagglutination and inhibition assay 
After species selection, we began the assay by confirming the hemagglutination activity and the 
sugar specificity of the selected total protein extract. For this, we evaluated the hemagglutinating 
unit of the total extract against rabbit erythrocytes solution at 4% (v/v). Then, using four 
hemagglutinating units, we were able to see the inhibition of this same activity using a panel of 
carefully selected sugars.  
These sugar selection is related to two main reasons: to try to classify the lectins present in our 
sample based on the sugar specificity, but also to perceive their specificity to characteristic sugars 
of the glycomic aberration involved in the tumoral process, namely branched N-glycans and fucose. 
 
Our results suggest that we have detected three types of lectins in our protein extract, since, 
according to the sugars inhibition tests, we have inhibition for group IV (L-fucose) and the 
inhibition by glucosamine and galactosamine, could means that core molecules, glucose and 
galactose, can be part of the others groups like mannose/glucose (group I), galactose-N-acetyl-
galactosamine (group II) and N-acetly-glucosamine (group III), from lectins classification by sugar 
specificity. This suggests the importance of these proteins in the recognition of tumour cells, since 
these glycans are importance in tumour development.  
In aberrant glycosylation several sugars have a protagonist, as β1,6 branched and bisected N-
glycan  that modulates cell behavior by interfering in the physical and performance properties of 
glycosylated adhesion molecules on the cell surface; a poly-N-acetyllactosamine-containing 
glycans, that can be potentially recognized by galectins and a outer-chain polyfucosylation and 
sialyl Lewisx production that are potentially recognized by the selectins. 
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Figure III.2 – Hemagglutination and inhibition of hemagglutination by sugar assays from Arbutus 
unedo leaves total protein extract. A – Hemagglutination activity: serial dilution (1:3) of total protein 
extract (50 µg of protein, Aun), negative (C-; saline) and positive (C+; Con A) controls. B1, B2 and B3 –
Hemagglutination activity inhibition by sugar of total protein extract (4 H.U.: 0.0916 µg per well). 
Sugar inhibition Sugar minimal 
inhibitory 
concentration 
(m.i.c.) (mM) 
Maximal protein 
concentration 
inhibited (4 H.U.) 
(µg) 
1- D-Glucose - - 
2- D-Glucosamina 11.1 9.16 x 10-2 
3- N-Acetyl-D-
glucosamine 
- -- 
4- D-Galactose - - 
5- D-Galactosamina 11.1 9.16 x 10-2 
6-N-Acetly-D-
galactosamine 
- - 
7- Lactose - - 
8- D-Mannose - - 
9- Raffinose - - 
10- D-Fucose - - 
11- Melezitose - - 
12- α-Methly-D-
glucopyranoside 
- - 
13- α-Metly-D-
mannopyranoside 
- - 
14- Sucrose 100 9.16 x 10-2 
16- Sialic acid - - 
17- L-Fucose 11.1 9.16 x 10-2 
A 
B1 
B2 
B3 
C 
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Carbohydrates used 1- glucose (0.1 M); 2-glucosamine (0.1 M); 3- N-acetyl-D-glucosamine (0.1 M); 4- 
galactose (0.1 M); 5- galactosamine (0.1 M); 6- N-acetyl-D-galactosamine (0.1 M); 7- lactose (0.1 M); 8- 
mannose (0.1 M); 9- raffinose (0.1 M); 10- D (+) fucose (0.3 M); 11- melezitose (0.1 M); 12- methyl-α-
glucopyranoside (0.1 M); methyl-α-mannoside (0.1 M); 14- saccharose (0.1 M); 16- N-acetylneuraminic 
acid (0.1 M) and 17- L (-) fucose (0.3 M). C – Sugar inhibition of the hemagglutination activity analyses.  
(-) showed no inhibition of hemagglutination activity. 
 
2.1.2. Polypeptide binding to HT29 cells membranes 
Before proceeding with protein purification, we confirmed the proteins extract binding to HT29 
cell membranes. For that we incubated protein extract with isolated HT29 membranes and analysed 
the polypeptide profile of the incubation product by electrophoresis. Results are in Figure III.3. 
 
 
Figure III.3 - Analysis of Arbutus unedo proteins extract binding to the HT29 cells membranes. 
Electrophoretic profile on SDS-PAGE R gel, 17.5% (w/v) acrylamide and AgNO3 staining. Were applied 3 
µL of mass molecular marker (M), 13 µg of HT29 isolated membrane (HT29), incubated with saline, 50 µg 
of Arbutus unedo total protein extract (Aun), as membrane and extract controls, respectively, and 13 µg of 
incubation membrane (Aun + HT29). 
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The assay of Arbutus unedo protein binding to HT29 cell membranes analysis by SDS-PAGE 
R showed that there were at least 3 bands that bound to HT29 cell membranes with molecules mass 
of around 25 kDa, 29 kDa and 50 kDa. Since lectins are comprising of 25–30 kDa subunits and as 
they were in presence of 2-mercaptoethanol, we could be in the presence of 2 subunits of the same 
lectin or more lectins, if they have not disulphide bonds.  
These results can be address only to lectins that bind to glycosylated receptors of HT29 cells 
membranes, however lectins can be internalized into the cell and act by mitochondrial pathway, 
what we can´t see by polyacrylamide gel. 
 
 
3. Arbutus unedo lectins purification by ionic-exchange 
chromatography 
3.1. Anionic-exchange chromatography in Q-Sepharose  
After confirming the presence of lectins in the Arbutus unedo total protein extract and its binding 
to HT29 cell membranes, we started the fractionation process using Q-Sepharose (Figure III.4A). 
The polypeptide profile of all samples collected in this process, unadsorved fraction and eluted 
polypeptides, were analysed by SDS-PAGE R gel (Figure III.4B). For all samples, the presence of 
lectin-like proteins was investigated by hemagglutination assays, against a solution of rabbit 
erythrocytes at 4% (v/v). 
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Figure III.4 - Arbutus unedo protein fractionation by anionic-exchange chromatography followed 
SDS-PAGE R gel. A – The total protein extract was applied on a Q-Sepharose column equilibrated in buffer 
A (50 mM Tris-HCl, pH 7.5, containing 2 mM CaCl2 and 2 mM MgCl2). The buffer B (50 mM Tris-HCl, 
pH 7.5, 1 M NaCl, containing 2 mM CaCl2 and 2 mM MgCl2) as the elution buffer, with a stepwise gradient: 
0-20% step gradient in 4 column volumes (CV), 20-30% in step gradient 4 CV, 30-40% 3 CV, with later 
linear gradient of 40-60% 2 CV and finally step gradient 60-100% in 3 CV, by adding buffer A and B. The 
flow of the buffer solution was 1 mL/min. Elution of the proteins was continuously recorded by reading the 
absorbance at 280 nm. B1 and B2 - SDS-PAGE R 17.5% (w/v) acrylamide gels and AgNO3 staining. 
Polypeptide profile of the diverse eluates collected during fractionation. Were applied 3 µL of molecular 
mass markers (M), 40 μg of total extract protein of Arbutus unedo (Aun); 20 μg of unadsorbed protein 
fraction and 7 μg of each eluate (E1-E16). 
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At a first glance the polypeptide profile of some eluates appears promising as some of them 
have fairly representative bands of the same molecular weight as the bands that bound to the 
membranes of HT29 cells (Figure III.3). In particular, the eluate 2 shows ≈ 25 and ≈ 29 kDa bands, 
the eluates 3 to 5 have ≈ 50 kDa band, and in eluates 8 to 12 a band at ≈ 29 kDa is present, however 
these are not the most representative. In addition to these bands that appear to be the same that than 
those bind to HT29 cells membrane, another representative bands, namely in eluates 2 and 3, with 
molecular weights of ≈ 15 kDa, appear to be also compatible with the typical lectin subunit 
molecular weight. 
 
3.2. Hemagglutination and inhibition of hemagglutination assays 
In order to identify the fractions with lectin-like proteins, we carried out the tests with the 
hemagglutination activity study, applying for each sample 50 μg of protein with 12 dilutions (1:3) 
and always with a negative control (saline) and a positive control (Con A). This assay was 
performed against rabbit erythrocytes solution at 4% (v/v). None of the eluates showed 
hemagglutination activity, however, the unadsorbed Q-Sepharose column fraction showed a very 
strong hemagglutination activity with a H.U. of 8.47 x 10-4 μg.  
We proceeded with the inhibition of hemagglutination activity by sugars study only with 
unadsorbed Q-Sepharose column fraction (Table III.1). For this sample, the same panel of sugars 
tested in the Arbutus unedo total protein extract was performed in the same conditions. 
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Table III.1 -Hemagglutination activity and sugars specificity of unadsorbed Q-Sepharose fraction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Fucose (0.3 M) 
 
Table III.1 shows the results of hemagglutination activity inhibition by sugars. In addition to 
sugars that inhibited hemagglutination activity in the total protein extract, α-metly-D-
mannopyranoside also showed inhibition the hemagglutination activity for the unadsorbed fraction 
to the Q-Sepharose column. This shows that the total extract probably has some protein that 
inhibited the action of lectins with specificity to α-metly-D-mannopyranoside sugar.  
A glycoprotein detection assay for total protein extract, could give a panel of total glycoproteins 
that can act as inhibitor. These results show that we continue to have lectins from group I, group II 
and group IV, with one more specific sugar with core mannose, added to core glucose and 
galactose, according to the classification based on carbohydrate specificity. 
Sample Hemagglutination 
Unit (H.U.)  
(µg) 
Sugar inhibition 
(0.1 M) 
Sugar minimal 
inhibitory 
concentration 
(m.i.c.) (mM) 
Maximal protein 
concentration 
inhibited (4 H.U.) 
(µg) 
Unadsorbed 
Q-Sepharose 
8.47 x 10 -4 
1- D-Glucose - - 
2- D-Glucosamina 3.7 3.39 x 10 -3 
3- N-Acetyl-D-glucosamine - - 
4- D-Galactose - - 
5- D-Galactosamina 1.23 3.39 x 10 -3 
6-N-Acetly-D-galactosamine - - 
7- Lactose - - 
8- D-Mannose - - 
9- Raffinose - - 
10- D-Fucose* - - 
11- Melezitose - - 
12- α-Methly-D-
glucopyranoside 
- - 
13-α-Metly-D-
mannopyranoside 
<0.56 x 10 -3 3.39 x 10 -3 
14- Sucrose <0.56 x 10 -3 3.39 x 10 -3 
16- Sialic acid - - 
17- L-Fucose* < 1.7 x 10 -3 3.39 x 10 -3 
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3.3. Unadsorbed Q-Sepharose lectins purification by carbohydrate affinity 
columns 
Three affinity columns were used with carbohydrate ligands: N-acetyl-D-glucosamine (Vector), 
D-galactose (Pierce) and N-acetyl-D-galactosamine. These columns were selected based on the 
previous sugars inhibition tests performed on total protein extract and unadsorbed Q-Sepharose 
fraction.  
After carrying out the running on these columns (Figure III.5.A), the hemagglutination activities 
were performed with rabbit erythrocytes at 4% (v/v) for all eluates (with 50 μg of protein), in order 
to evaluated the present of lectins (Figure III.5.B). These fractions don’t reveal hemagglutination 
activity from the three affinity columns, however all unadsorbed fractions showed 
hemagglutination activity. For the samples that had hemagglutination activity the polypeptide 
profile was evaluated on a SDS-PAGE R gel. 
 
Fraction (50 µg) H.U. (µg) 
Unadsorbed N-Acetyl-D-glucosamine 1,852 
Unadsorbed D-Galactose 1,852 
Unadsorbed N-Acetyl-D-galactosamine 0,2058 
 
 
 
 
 
 
 
 
 
Figure III.5 – Polypeptide profile analysis of affinity columns unadsorbed fractions and 
hemagglutination activity. A - SDS-PAGE R, 17.5% acrylamide (w/v) and AgNO3 staining. Were applied 
3 μL of molecular  mass markers, 6 μg of Arbutus unedo total protein extract (Aun) and 10 μg of unadsorbed 
fractions, from Q-Sepharose column (Unds Q-Seph), N-acetyl-D-glucosamine column (Unds GlNAc), D-
B A 
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galactose column (Unds Gal) and N-acetyl-D-galactosamine column (Unds GalNAc). B – Hemagglutination 
unit (H.U.) from affinity unadsorbed fraction was performed a serial dilution (1:3) of 50 µg of each sample. 
 
The polypeptide profile analysis showed that all unadsorbed fractions have some common 
bands, in particular the ≈ 29 kDa molecular weight band, who is one of the bands that binds to 
HT29 cells membranes. However, there is a quite evident band, common to all samples, the ≈ 15 
kDa band. The unadsorbed N-acetyl-D-galactosamine column sample was the sample with has a 
stronger band at ≈ 15 kDa and is also the sample with lower hemagglutinating unit (H.U. of 0.2058 
µg). These observations may be indicative for a lectin with 15 kDa subunits, since it is commom 
band to all samples which show hemagglutination activity. 
 
3.4. Unadsorbed Q-Sepharose lectins purification by cationic-exchange 
chromatography in Mono S column 
Since lectins could not be purified by affinity columns, it was decided to proceed with the lectins 
purification with the unadsorbed Q-Sepharose column fraction. The next purification step was to 
know what the pH that we can work on Mono S column without loss of sample hemagglutination 
activity. The sample at different pH (pH 2.0, 2.5, 3.0, 3.5 and 4.0) was tested and it was verified 
that the low pH did not influence the hemagglutination activity of the sample, the pH 2.0 was 
selected.  
After selecting the working pH, the next step consisted on the application of the unadsorbed Q-
Sepharose fraction in the Mono S column (Figure III.6). After collecting the unadsorbed fraction 
and elution peak fraction the hemagglutination activity was assayed with 50 µg of protein from 
each fraction (Figure III.7). Only the unadsorbed fraction to Mono S column showed activity, and 
for that fraction it was performed a SDS-PAGE R gel in order to analysed the polypeptide profile. 
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Figure III.6- Representative chromatogram of Mono S column. Proteins fractionation by Mono S 
column, a strong cation exchanger (Resource S), having a working buffer A (20 mM phosphoric acid and 
NaOH, pH 2.0, 2 mM CaCl2 and 2 mM MgCl2); with the elution buffer B (20 mM phosphoric acid and 
NaOH, pH 2.0, 1 M NaCl, 2 mM CaCl2 and 2 mM MgCl2). The flow of the buffer solution was 1 mL/min. 
Elution of the proteins was continuously recorded by reading the absorbance at 280 nm.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III.7- Unadsorbed Q-Sepharose lectins purification by Mono S column. A - Hemagglutination 
unit (U.H.) from total protein extract, unadsorbed Q-Sepharose column and unadsorbed Mono S column 
samples. Serial dilution (1:3) of 50 µg of each sample. B - SDS-PAGE R 17.5% (w/v) acrylamide and 
AgNO3 staining. Were applied 3 µL of molecular mass markers (M), 5 μg of total extract protein of Arbutus 
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unedo (Aun); 11 μg of protein that not bound to the Q-Sepharose column (Unds Q-Seph) and 13 μg of 
protein that was not bound to the Mono S column (Unds Mono S). 
 
In relation to the hemagglutination activity assay and comparing the three samples present in 
figure III.7, we can conclude that the unadsorbed fraction to the Q-Sepharose column is the one 
that presents the best result, in other words, it is the sample that needs the least amount of protein 
to induce erythrocytes hemagglutination. Perhaps, this fact consists in a lectin that could be 
denaturated at the work pH of Mono S column, with loss of activity. 
 
 The difference between hemagglutination activity of total protein extract and unadsorbed Q-
Sepharose fraction, could be addressed to a possible inhibition of lectins activity of extract by 
proteins like glycoproteins. We can also consider that the preliminary purification on Q-Sepharose 
column could remove some of these glycoproteins. 
When we analyze the polypeptide profile, we find that the Unds Q-Seph sample contains the 
bands that bound to the HT29 cells membranes, ≈ 25 kDa, ≈ 29 kDa and ≈ 50 kDa, but also has a 
band at ≈ 15 kDa, with great intensity. This band is the most representative in the unadsorbed Mono 
S column sample. The ≈ 15 kDa band is also common to unadsorbed affinity column samples, so 
we can conclude that this band is common to all samples that showed hemagglutination activity, 
alerting us to the possibility of this band may correspond to a lectin subunit. 
 
4. Proteomic analysis (2D) of purified lectins binding to HT29 cells 
Since the profile of the unadsorbed Mono S sample is very simple, and this sample shows good 
hemagglutination activity, it was decided to carry out the proteomic analysis of the binding of this 
sample to the HT29 cells membranes glycosylated receptors. 
The use of two-dimensional electrophoresis technique in this work aimed to increase the 
resolution in the separation of proteins in order to allow the identification of its various isoforms, 
with molecular weight and isoelectric point characterization. 
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Figure III.8 – Two-dimensional analysis of lectin, present in unadsorbed Mono S fraction, bound to 
HT29 cell membranes. IEF (1D) with a pH gradient (3-10 pH) performed for all samples. For HT29 
membranes 1 mg of protein was applied (A), for unadsorbed Mono S fraction it was applied 500 µg of 
protein (B) and 1500 µg of total protein for unadsorbed fraction (500 μg) incubated with HT29 cells 
membrane (1 mg) (C). The strips were overlapped onto an SDS-PAGE with 17.5% (w/v) acrylamide; the 
gel was staining by AgNO3. 
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The results of the unadsorbed Mono S proteins that bind to the HT29 cell membranes and the in 
resolution by two-dimensional analysis show that the proteomic profile of the purified sample is in 
fact very simple, presenting predominant four peptide spots. The most representative peptide has a 
molecular weight of ≈ 15 kDa, with pI between 4.5 and 5, then there are two spots with molecular 
masses between ≈ 60-63 kDa and pI between 5 and 6 and finally, and with less representativeness, 
a spot with molecular mass of ≈ 50 kDa and pI between 4.5 and 5. All polypeptide spots are acidic. 
When we compared the polypeptide gel profile in which we applied the binding sample with 
the control gel (Figure III.8.A), which represents the proteins membranes profile, we noticed that 
there is a band (Figure III.8.C) which is not part of the membranes profile, but belongs to the 
purified sample profile (Figure III.8.B), the band of molecular weight of ≈ 15 kDa with pI between 
4.5 and 5. In fact, when we look at the polypeptide profile of the other studied samples that had 
hemagglutination activity, we see that this band, with molecular weight of ≈ 15 kDa, is always 
present. 
 
5. Final evaluation of antitumor activity of purified lectin(s) in HT29 cells 
The purified lectins (unadsorbed proteins to Mono S column) from Arbutus unedo leaves protein 
extract were assayed for antitumoral activity. For this purpose, HT29 cells were exposed to 25, 50, 
100 and 250 µg/mL of total protein extract and to purified lectin, for 72 h. Cell viability and cell 
death were evaluated by MTS metabolism and LDH release assays, respectively (Figure III.9). 
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Control 
 
 
Figure III.9 – Cytotoxicity evaluation of total protein extract and purified lectins in HT29 cells. HT29 
were exposed to 25, 50, 100 and 250 µg/mL of total extract and purified lectin or no addition (control) for 
72 h. Saline containing 2 mM CaCl2 and 2 mM MgCl2 was used as a control. General cell death (A) and cell 
viability (B) were evaluated by LDH release and MTS metabolism assays, respectively. Representative 
microscopy images at 100x original magnification (C). Results are expressed as mean ± SEM fold-change 
to control from three independent experiments *p <0.01 and †<0.05 from control HT29 cells. 
 
Our results show that total protein extract and purified lectins have the ability to induce cell 
death and decrease MTS metabolism in a concentration dependent manner (Figure III.9.A e B). 
However, the total protein extract induces more general cell death, and a strong decrease in MTS 
metabolism. In addition, Figure III.9.C shows that the total protein extract at 100 µg/mL drastically 
reduces the number of cells. At 250 µg/mL, the few cells still present are extremely picnotic. 
When we analyzed the results for the purified sample we found that both the increase in LDH 
activity and the decrease in the MTS metabolism are less pronounced than those of the total protein 
extract (Figure III.9.A e B). We may conclude that the total protein extract may have other proteins, 
in addition to lectin, which may also be of lectin type (synergism) that strongly increased 
cytotoxicity. 
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It is well established that lectins are potent proteins with antitumoral activity due to apoptosis 
(Yau et al., 2015). Activation of caspases has been shown to be a hallmark of lectin-induced cancer 
cell by apoptosis (Shi et al., 2016). Therefore, caspase-3/7 activation was evaluated, using HT29 
cells exposed to either 25 µg/mL of total protein extract, 25 or 100 µg/mL of purified lectin, or no 
addition (control) for 24 h (Figure III.10.A). Moreover, changes in nuclear morphology were 
evaluated by fluorescence microscopy of Hoechst stained nuclei, following exposure to either 25 
µg/mL of total protein extract, 100 µg/mL of purified lectin, or no addition (control) for 24 h, to 
detect apoptotic nuclei (Figure III.10.B). 
 
 
 
 
Figure III.10 – Assessment of apoptosis induced by total protein extract and purified lectins in HT29 
cells. Cells were exposed to 25 µg/mL of total protein extract, 100 µg/mL of purified lectin or no addition 
(control) for 72 h. Saline containing 2 mM CaCl2 and 2 mM MgCl2 was used as a control. (A) Caspase-3/7 
activity was determined at 24 h after cell exposure. (B) Nuclear morphology was evaluated after Hoechst 
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staining by fluorescence microscopy at 24 h of cell exposure. Representative images of Hoechst staining at 
400x original magnification. Arrows indicate nuclear fragmentation and chromatin condensation. Results 
expressed as mean ± SEM fold-change to control, from 3 independent experiments. *p <0.01 from HT29 
cells. 
 
The results suggest that under these experimental conditions, caspases are not activated and 
nuclear fragmentation is also not evident. Nevertheless, more studies are needed to conclude that 
apoptosis in not involved in lectins cytotoxicity. 
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Chapter IV – Final conclusions and future perspectives 
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The work developed in this thesis allowed to purify lectin(s) from leaves of Arbutus unedo total 
protein extract that exhibit antitumor activity and lectin activity. It was concluded that purified 
lectin(s) has the ability to induce cell death and decrease MTS metabolism.  
Based on our results we can conclude that the purified lectin, with ≈ 15 kDa molecular weight, 
binds to glycosylated receptor in the HT29 cells surface and most likely induces cell death. We 
may also suggest that the Arbutus unedo total protein extract has another(s) lectin(s) that can act 
like antitumoral agents but by inhibition of cellular proliferation, based on the results of MMP2 
and MMP9 inhibition assays, determined in previous work, associated with the LDH and MTS 
results of total protein extract. These results reveal that this species is an excellent reservoir of 
lectins with antitumor activity once Arbutus unedo leaves contain lectins that are antitumoral 
agents. They may act by synergic mechanisms with inhibition of cellular proliferation that can be 
used in the metastatic process control of the and cellular death by necrosis.   
The purified lectin with a molecular weight of ≈ 15 kDa, should be sequenced. Since it was not 
possible to determine the inhibition of hemagglutination activity by sugars, it would be interesting 
to do so. After this determination, it could still be ascertained whether this lectin has the ability to 
induce death in normal colon fibroblasts, to determine the binding specificity of this protein. 
Although cell death may not occur through apoptosis, this protein may be interesting as an identifier 
of tumor cells, or function as a drug delivery tool, in case specificity for the glycosylated receptors 
of tumor cells is demonstrated. Binding to these cells would be specific and could be detected at 
the beginning of the disease. 
Throughout the separation process, other lectins, capable of binding to the HT29 cells 
membranes, have been detected. Therefore, this species may contain other lectins, namely, lectins 
that did not resist to pH 2. It would be interesting to have another purification method that does not 
involve the use of low pH solutions. After further purification, we would repeat all 
hemagglutination activity assays and the inhibition by sugars for the new fractions. 
 
In summary, lectins are proteins with excellent antitumor capacity. There are still many species 
in our flora to study further, which may be promising in relation to the presence of lectins with 
these capacities. 
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